Introduction {#s1}
============

Proteins execute diverse functions by interacting with multiple protein partners in different complexes. The study of protein complex structures and protein-protein interactions is critical for understanding their functions. Recently, chemical cross-linking of proteins coupled with mass spectrometry analysis (CXMS) has emerged as a powerful tool for the analysis of such structures and interactions ([@bib68]; [@bib37]; [@bib54]; [@bib67]; [@bib56]; [@bib6]). CXMS methods are less time-consuming and less demanding of sample purity than are traditional methods; this technology has thus been increasing in popularity.

Recent progress in the development of analytical instruments, cross-linking reagents, and software has catapulted CXMS from obscurity to prominence, as witnessed by an explosion of successful applications ([@bib4]; [@bib10]; [@bib29]; [@bib35]; [@bib20]; [@bib24]; [@bib26]; [@bib30]; [@bib36]; [@bib7]; [@bib48]; [@bib72]). However, CXMS is still limited by sample complexity and by low abundances of cross-linked peptides. Extensive fractionation is often required to reduce the complexity of samples that contain macromolecular complexes ([@bib10]; [@bib35]; [@bib24]; [@bib26]; [@bib30]; [@bib48]; [@bib72]). The identification of cross-linked peptides in more heterogeneous samples such as crude immunoprecipitates and whole-cell lysates is even more difficult ([@bib57]; [@bib43]; [@bib83]; [@bib40]).

Given the sparsity of cross-linked peptides in samples, it would be beneficial to purify them from complex mixtures using affinity tags after cross-linking. However, despite increased efforts to develop chemical cross-linkers with enrichment functions ([@bib43]; [@bib73]; [@bib18]; [@bib12]; [@bib13]; [@bib11]; [@bib28]; [@bib49]; [@bib82]; [@bib76]; [@bib55]; [@bib69]; [@bib25]), few such agents have been shown to improve identification capabilities in complex samples. Two exceptions include Azide-A-DSBSO, which is used with biarylazacyclooctynone ([@bib25]), and the protein interaction reporter (PIR) ([@bib9]; [@bib80]). However, special instrument control is recommended for their application ([@bib9]; [@bib80]).

In this work, we developed a series of chemical cross-linkers with a modular design as pioneered previously ([@bib73]). They each contain a biotin tag for affinity purification and a cleavage site that can be used to release cross-linked peptides from streptavidin beads. We selected the cross-linker with the best performance and developed a robust enrichment protocol with \>97% enrichment efficiency. We termed it [L]{.ul}ysine-targeted [e]{.ul}nrichable cross-l[i]{.ul}n[ker]{.ul} (Leiker). Using our previously developed pLink identification software ([@bib83]), we here demonstrate that the use of Leiker effectively facilitates CXMS analysis in a variety of sample types, from purified complexes, crude immunoprecipitates, to highly complex whole-cell lysates.

Quantification of cross-linker modified peptides has the potential to detect protein conformational changes and changes in molecular interactions, though these methods are not mature. To address this potentially critical application of our technology, we synthesized stable isotope-labeled Leiker. Also, we established an automated data analysis workflow for the relative quantitation of light and heavy Leiker cross-links. As a proof of concept, we carried out a quantitative CXMS analysis of an RNA-binding protein L7Ae. Using deuterium-labeled Leiker, we found that for the three L7Ae lysine residues that are buried upon RNA binding, their mono-links decreased dramatically in the presence of RNA, exactly as expected. We further extended the application of quantitative CXMS to a highly complex system consisting of log-phase and stationary-phase *E. coli* cells and identified a growth phase specific protein interaction.

Results {#s2}
=======

Design, synthesis and evaluation of Leiker {#s2-1}
------------------------------------------

We aimed to develop a cross-linker similar to the widely used BS^3^ but that had two major advantages: first, a biotin tag for affinity purification of cross-linked peptides, and second, a cleavage site to release cross-linked peptides after enrichment on streptavidin beads without carrying the biotin group; biotin can interfere with subsequent LC-MS/MS analysis. After experimenting with different designs of Leiker ([Figure 1](#fig1){ref-type="fig"}, [Figure 1---figure supplements 1](#fig1s1){ref-type="fig"}--[6](#fig1s6){ref-type="fig"}, and Appendix), we found that bAL1 and bAL2 worked the best and there was no difference in performance between these two ([Figure 1---figure supplement 5](#fig1s5){ref-type="fig"}). Hereafter, Leiker refers to either bAL1 or bAL2. In this study, bAL2 was used in most of the experiments and a bAL2-based CXMS workflow is illustrated in [Figure 2](#fig2){ref-type="fig"}. Both bAL1 and bAL2 feature a one-piece design with an azobenzene-based chemical cleavage site ([@bib84]) and a 9.3-Å carbon chain that connects two sulfo-NHS esters. This spacer arm is shorter than that of BS^3^ (11.4 Å), so it may confer a higher specificity to Leiker in capturing protein-protein interactions. Inter-, loop-, and mono-linked peptides generated by either all produce a reporter ion of *m/z* 122.0606 in higher-energy collisional dissociation (HCD) spectra ([Figure 2D](#fig2){ref-type="fig"}). It can be used to verify the identification of Leiker-cross-linked peptides. For quantitative CXMS analysis, we synthesized isotope-labeled bAL2 in which six hydrogen atoms in the spacer arm were replaced with deuterium ([Figure 1](#fig1){ref-type="fig"} and [Figure 1---figure supplement 6](#fig1s6){ref-type="fig"}). The six-dalton difference was sufficient to separate peptides cross-linked by \[d~0~\]-Leiker from the same peptides cross-linked by \[d~6~\]-Leiker.10.7554/eLife.12509.003Figure 1.Chemical structures of different designs of Leiker.The top panel shows four designs of two-piece Leiker with a photo-cleavage site (sulfo-PL, PL, and PEG-PL) or an azobenzene-based cleavage site (AL). Biotin is attached via click chemistry by reacting with bio-aizde. The bottom panel shows two unlabeled (bAL1, bAL2) and deuterium-labeled (\[d~6~\]-bAL2) one-piece Leiker molecules. The biotin moiety is colored magenta.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.003](10.7554/eLife.12509.003)10.7554/eLife.12509.004Figure 1---figure supplement 1.Optimization of protein-to-cross-linker ratio (w/w) for (**A**) sulfo-PL, (**B**) AL, (**C**) bAL1, and (**D**) bAL2.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.004](10.7554/eLife.12509.004)10.7554/eLife.12509.005Figure 1---figure supplement 2.Evaluation of azobenzene-based chemical cleavage.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.005](10.7554/eLife.12509.005)10.7554/eLife.12509.006Figure 1---figure supplement 3.The one-piece Leiker (bAL1) outperformed the two-piece Leiker (AL) in the CXMS analysis of a mixture of ten standard proteins.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.006](10.7554/eLife.12509.006)10.7554/eLife.12509.007Figure 1---figure supplement 4.Evaluation of the two piece Azo-Leiker (AL).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.007](10.7554/eLife.12509.007)10.7554/eLife.12509.008Figure 1---figure supplement 5.bAL1 and bAL2 performed similarly.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.008](10.7554/eLife.12509.008)10.7554/eLife.12509.009Figure 1---figure supplement 6.MS1 spectra of (**A**) \[d~0~\]-bAL2 and (**B**) \[d~6~\]-bAL2.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.009](10.7554/eLife.12509.009)10.7554/eLife.12509.010Figure 2.Scheme of the Leiker-based CXMS workflow.(**A**) Leiker contains a biotin moiety (magenta), a cleavage site (arrows), and six hydrogen atoms that are accessible to isotope labeling (asterisks). (**B**) The workflow for purification of Leiker-linked peptides. (**C**) Three types of Leiker-linked peptides. (**D**) Leiker-linked peptides generate a reporter ion of 122.06 *m/z* in HCD, as shown in the spectrum of an inter-linked peptide NYQEAKDAFLGSFLYEYSR-LAKEYEATLEECCAK (+4 charged, MH^+^ 4433.0553), in which C denotes carbamidomethylated cysteine.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.010](10.7554/eLife.12509.010)

Leiker enabled robust enrichment of cross-linked peptides {#s2-2}
---------------------------------------------------------

To assess to what extent Leiker could improve the identification of low-abundance cross-linked peptides from a complex background, a mixture of ten standard proteins ([Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}), consisting of RNase A, lysozyme, PUD-1/PUD-2 heterodimer, GST, aldolase, BSA, lactoferrin, β-galactosidase, mouse monoclonal antibody, and myosin, was treated with Leiker, digested with trypsin, and then diluted or not with a tryptic digest of non-cross-linked *E. coli* lysates at different ratios (1:1, 1:10, and 1:100, w/w). The peptide mixture was then incubated with streptavidin agarose. After extensive washes, cross-linked peptides were released using the Na~2~S~2~O~4~ elution buffer. BS^3^ was used in parallel as a control. As is shown in [Figure 3A](#fig3){ref-type="fig"} the number of BS^3^-linked peptide pairs identified decreased dramatically, from 109 in the undiluted sample to only one in the 100-fold diluted sample. The number of Leiker-linked peptide pairs identified after enrichment was in no way affected by increasing background complexity, with \>160 inter-links detected in each sample. To be noted, these inter-linked peptide pairs, or inter-links for abbreviation, can result from either intra-protein or inter-protein cross-linking (illustrated in [Figure 2B](#fig2){ref-type="fig"}). Strikingly, cross-linking products, including inter-, loop- and mono-links ([Figure 2C](#fig2){ref-type="fig"}) constituted over 97% of all peptides identified post enrichment ([Figure 3A](#fig3){ref-type="fig"}). Of the Leiker-linked lysine pairs that can be mapped to the pdb structures ([Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}), 82% have Cα -- Cα distance ≤22 Å and 93% have Cα -- Cα distance ≤30 Å (FDR \< 5%, E-value \< 0.01), which is comparable to BS^3^ ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). This result demonstrated that Leiker enables effective enrichment of cross-linked peptides.10.7554/eLife.12509.011Figure 3.Evaluating the performance of Leiker.(**A**) Leiker allowed near 100% enrichment of target peptides from a cross-linked ten-protein mixture diluted with increasing amounts of non-cross-linked *E. coli* lysates. Dark blue, inter-links; light blue, mono-links; green, loop-links; grey, regular peptides not modified by Leiker. (**B**) Number of cross-link identifications from *E. coli* lysates treated with Leiker or BS^3^. Shown in the left and right panels are the identified spectra and peptides, respectively.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.011](10.7554/eLife.12509.011)10.7554/eLife.12509.012Figure 3---source data 1.Ten standard proteins used to evaluate Leiker, mixed at equal amounts by mass.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.012](10.7554/eLife.12509.012)10.7554/eLife.12509.013Figure 3---source data 2.Summary of identified spectra from the ten-protein mixture.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.013](10.7554/eLife.12509.013)10.7554/eLife.12509.014Figure 3---figure supplement 1.Distance distributions of cross-linked lysine pairs in the undiluted ten-protein mixture.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.014](10.7554/eLife.12509.014)

The ten standard proteins also allowed us to assess the specificity of Leiker. Because Leiker has more functional groups than BS^3^ does, a concern arises that Leiker may produce more cross-linking artifacts. Cross-links between non-interacting proteins are surely artifacts, which include all the inter-protein cross-links identified from the ten-protein mixture except those between the light-chain and the heavy-chain of myosin, between the light-chain and the heavy-chain of an IgG antibody, and between PUD-1 and PUD-2, which form a heterodimer. We found that the percentage of artifactual cross-links is 3% for both Leiker and BS^3^ ([Figure 3---source data 2](#SD2-data){ref-type="supplementary-material"}), fitting with the filtering criteria that were applied (FDR cutoff 0.05 followed by E-value cutoff 0.01). The results demonstrate that Leiker is as specific as BS^3^.

Further, we cross-linked highly complex *E. coli* lysates with either Leiker or BS^3^ for a side-by-side comparison. After enrichment and a single reverse phase LC-MS/MS analysis, Leiker yielded at least a fourfold increase in the number of inter-links identified ([Figure 3B](#fig3){ref-type="fig"}).

Application of Leiker to large protein assemblies and immunoprecipitates {#s2-3}
------------------------------------------------------------------------

Next, we applied Leiker to real-world samples, starting with purified *E. coli* 70S ribosome, a 2.5 MDa ribonucleoprotein (RNP) complex consisting of more than 50 proteins. A total of 222 inter-linked lysine pairs were identified with high confidence, including 95 inter-molecular and 127 intra-molecular cross-links ([Figure 4---source data 1](#SD3-data){ref-type="supplementary-material"}). This is three times as many as in a previous study ([@bib35]). Of the 95 cross-links connecting two lysine residues that are both present in the crystal structure of a 70S ribosome ([@bib17]) (PDB code: 5AFI), 75% are compatible with the crystal structure with a Cα-Cα distance ≤22 Å, which is the length of the spacer arm of Leiker plus two lysine side chains. Among the subset of intra-molecular cross-links, 84% have Cα-Cα distances ≤22 Å; among the subset of inter-molecular cross-links, 50% have Cα-Cα distances ≤22 Å and 73% have Cα-Cα distances ≤30 Å, which could be a reasonable cutoff considering conformation flexibility of proteins in solution ([Figure 4---source data 1](#SD3-data){ref-type="supplementary-material"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). One particular ribosomal protein L9 is a good example to illustrate conformational flexibility and the dynamic nature of interactions between proteins or protein complexes. A large *b*-factor in the crystal structure has suggested that L9 is highly mobile. It has been observed to adopt an extended, rod-like conformation in the crystal structure ([@bib62]) and a strikingly different bent conformation in the solution structure of the ribosome determined using cryo-EM ([@bib17]; [@bib63]). Bending of L9 was echoed in this study, as reflected in the cross-links bridging L9 and L2 and the cross-links bridging the two termini of L9 ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}). Three additional cross-links involving L9 have Cα-Cα distances \>50 Å if measured within a ribosomal particle ([Figure 4---source data 1](#SD3-data){ref-type="supplementary-material"}). We propose these apparently long distance cross-links, which are similar to the ones observed in a previous CXMS study ([@bib35]), reflect interactions between ribosomal particles. L9 locates at the interface between ribosomal particles in higher-order configurations (*e.g.* polysome) ([@bib5]). Dimerization or oligomerization of 70S ribosomes in the absence of mRNA was also observed using negative staining EM from highly purified non-cross-linked 70S ribosomes ([Figure 4---figure supplement 3](#fig4s3){ref-type="fig"}).

The peripheral regions of the ribosome are critical for protein translation and regulation ([@bib61]; [@bib75]; [@bib33]). However, despite of extensive studies on the ribosome structures, these peripheral parts are still largely missing because they are either too dynamic or refractory to crystallography. For *E. coli* ribosomal proteins currently lacking well-defined coordinates in the 70S crystal structures, Leiker-based CXMS provided remarkably more linkages than other ribosomal proteins. The top four proteins with the most inter-molecular cross-links identified are S1, L1, L7/12, and L31, all of which are mobile components in the peripheral regions and often invisible in the crystal structure ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---source data 2](#SD4-data){ref-type="supplementary-material"}). S1 is the largest ribosomal protein, which binds to mRNA and initiates translation, but has no high-resolution structures available either alone or in the context of the 70S ribosome ([@bib17]; [@bib34]). A previous CXMS analysis of the 30S subunit revealed interaction between S1 and a region near the 3' end of 16S rRNA ([@bib34]), but it is unknown whether or not S1 interacts with the 50S subunit. Our analysis of the 70S ribosome revealed extensive contacts between the C-terminal mRNA binding domain of S1 and L1 in the 50S subunit ([Figure 4---figure supplement 4A](#fig4s4){ref-type="fig"}). Since the two of them localize to a region where both tRNA and mRNA leave the ribosome, the observation of six cross-links between them hints that there might be a coordination between deacylated tRNA release and mRNA exit from the ribosome. The 30S proteins that were found to interact with S1 in this study were largely consistent with those identified in the previous study ([@bib34]). In particular, four cross-links were identified between the N-terminal peptide of S1 (M1-K14) and the N-terminal peptide of S2 (M1-K11) ([Figure 4---source data 1](#SD3-data){ref-type="supplementary-material"} and [Figure 4---figure supplement 4A](#fig4s4){ref-type="fig"}). This result agrees perfectly with a recent structural finding on the direct interaction between S1 and S2 ([@bib8]). L1 had the highest number of cross-links with S1, followed by cross-links with L33, L5, L9, S13, and S2 ([Figure 4---figure supplement 4B](#fig4s4){ref-type="fig"}). The proximity of L1 to L33 and L5 implicates a rotated conformation of L1 in the sample ([Figure 4---source data 3](#SD5-data){ref-type="supplementary-material"}), which was repeatedly observed in various structures of the 70S ribosome in different functional states ([@bib75]). Furthermore, beyond the expected interactions between L7/12 and L6, L10, or L11 ([@bib15]), we also found novel interactions between L7/12 and L19 or S3 ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 4C](#fig4s4){ref-type="fig"}). These findings suggest that the highly flexible L7/12 stalk might be able to contact the 30S subunit, given the predicted large length of this dynamic stalk ([@bib15]). Nine cross-links between *E. coli* L31 and L5 placed L31 in the central protuberance region ([Figure 4---figure supplement 4D](#fig4s4){ref-type="fig"}), which is supported by the crystal structure of *T. thermophilus* 70S ribosome ([@bib77]) and the newly revealed structure of 70S ribosome ([@bib17]). Together, these results demonstrate that Leiker-based CXMS analysis can provide structural information that is highly complementary to crystallography and cryo-EM, especially for the flexible or dynamic regions that cannot be deduced using traditional methods.10.7554/eLife.12509.015Figure 4.Leiker-based CXMS analyses of large protein assemblies.(**A**) Analysis of a purified *E. coli* 70S ribosome revealed the locations of highly dynamic periphery ribosomal proteins S1, L1, and L7/12 that were refractory to crystallography and cryo-EM analysis. Cross-links to S1, L1, and L7/12 are colored red, blue, and yellow, respectively, and the cross-linked residues on these three proteins are numbered according to the Uniprot sequences. (**B**) Analysis of a crude immunoprecipitate of the yeast exosome complex. Dashed blue and grey lines denote 50 compatible and 22 incompatible cross-links, respectively, according to the structure of the RNA-bound 11-subunit exosome complex (PDB code: 4IFD). Rrp44, green; Rrp40, orange; Rrp4, violet; Rrp42, gold; other exosome subunits, yellow; RNA, black. Known and candidate exosome regulators revealed by Leiker-cross-links are shown along the periphery and highlighted in green and yellow circles, respectively. (**C**) Connectivity maps of the ten-subunit exosome core complex based on the inter-molecular cross-links identified in the current IP-CXMS experiments or on previous yeast two-hybrid (Y2H) studies ([@bib70]; [@bib74]; [@bib52]; [@bib44]; [@bib86]). Blue solid lines: experimentally identified putative direct protein-protein interactions; grey dashed lines: theoretical cross-links according to the crystal structure; Cα-Cα distance cutoff ≤30 Å.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.015](10.7554/eLife.12509.015)10.7554/eLife.12509.016Figure 4---source data 1.CXMS analysis of *E. coli* 70S ribosomes.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.016](10.7554/eLife.12509.016)10.7554/eLife.12509.017Figure 4---source data 2.Number of cross-linked lysine pairs classified by ribosomal proteins.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.017](10.7554/eLife.12509.017)10.7554/eLife.12509.018Figure 4---source data 3.Identified cross-linked lysine pairs involving L1.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.018](10.7554/eLife.12509.018)10.7554/eLife.12509.019Figure 4---source data 4.CXMS analysis of the *Saccharomyces cerevisiae* exosome complex.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.019](10.7554/eLife.12509.019)10.7554/eLife.12509.020Figure 4---figure supplement 1.Distance distribution of the inter-molecular and intra-molecular cross-links identified in 70S ribosomes.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.020](10.7554/eLife.12509.020)10.7554/eLife.12509.021Figure 4---figure supplement 2.Alignment of L9 and L2 from the crystal structure (L9, orange; L2, wheat; PDB code: 2AW4) and their counterparts from the cryo-EM reconstruction (L9, blue; L2, lightblue; PDB code: 5AFI).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.021](10.7554/eLife.12509.021)10.7554/eLife.12509.022Figure 4---figure supplement 3.Negative staining of non-cross-linked *E. coli* 70S ribosome.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.022](10.7554/eLife.12509.022)10.7554/eLife.12509.023Figure 4---figure supplement 4.Connectivity maps of cross-links involving (**A**) S1, (**B**) L1, (**C**) L7/12, and (**D**) L31.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.023](10.7554/eLife.12509.023)10.7554/eLife.12509.024Figure 4---figure supplement 5.Silver-stained SDS-PAGE gel of the crude immunoprecipitate of TAP-tagged Rrp46.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.024](10.7554/eLife.12509.024)10.7554/eLife.12509.025Figure 4---figure supplement 6.Number of identified inter-linked peptide pairs from decreasing amount of Leiker-cross-linked exosome immunoprecipitate (FDR \< 0.05, E-value \< 0.01).After enrichment, 30% (orange) or 60% (blue) of each sample was analyzed by LC-MS/MS.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.025](10.7554/eLife.12509.025)

Combining CXMS and immunoprecipitation (IP) has great potential for the detection of binding partners in close proximity among co-immunoprecipitated proteins; such method may be widely adopted in biology laboratories. Much progress has been made recently in this area by the use of a modified anti-GFP single-chain antibody that cannot be cross-linked so that GFP-tagged protein complexes can be cross-linked on beads and separated away from the antibody for CXMS analysis ([@bib65]). For highly heterogeneous IP samples, however, cross-linked peptides can be inundated by non-cross-linked peptides even if the antibody is removed from the background. As a test, we prepared a crude immunoprecipitate of a TAP-tagged yeast exosome subunit Rrp46 ([Figure 4---figure supplement 5](#fig4s5){ref-type="fig"}), from which 740 proteins were identified at 0.1% protein FDR. The immunoprecipitated proteins were eluted off IgG beads and cross-linked with Leiker. To evaluate the sensitivity of the method, we varied the amount of immunoprecipitates from 40 μg to 3 μg of proteins and found that the number of inter-link identifications did not change much as the input decreased from 40 to 20 μg ([Figure 4---figure supplement 6](#fig4s6){ref-type="fig"}). From three experiments starting with 40 μg of proteins, a total of 195 cross-linked lysine pairs (43 inter-molecular and 152 intra-molecular) were identified ([Figure 4B](#fig4){ref-type="fig"} and [Figure 4---source data 4](#SD6-data){ref-type="supplementary-material"}). Thanks to cross-linking, not only did we identify all ten exosome core subunits, but also 15 putative direct protein-protein interactions amongst the core subunits, which generated a connectivity map more complete than the one from yeast two-hybrid experiments ([@bib70]; [@bib74]; [@bib52]; [@bib44]; [@bib86]) and showed that among the co-immunoprecipitated proteins, Rrp41 and Rrp45 directly bind to the bait protein Rrp46 ([Figure 4C](#fig4){ref-type="fig"}). Of the cross-links identified, 69% were compatible with the crystal structure of an RNA-bound 11-subunit exosome complex ([@bib45]) (PDB code: 4IFD). Among the cross-links that disagreed with the RNA-bound structure, 68% involved the catalytic subunit Rrp44, which has a large rotation relative to the rest of the exosome core between the RNA-bound and the RNA-free states ([@bib45]; [@bib41]). The crude Rrp46 immunoprecipitate should mainly contain apo exosome, because magnesium was included in the buffer to activate the nuclease activity of exosome. Therefore, the presence (in the crystal structure) or absence (in our exosome preparation) of bound RNA is likely to be the primary reason behind most of the seemingly inconsistent inter-molecular cross-links.

To fulfill different functions in multiple biological processes ([@bib21]), the core exosome complex must recruit additional regulators, of which only a few are known. Here we found two known (Mpp6 \[[@bib47]\] and Ski7 [@bib1]) and four potential exosome regulators through nine cross-links with core exosome subunits ([Figure 4B](#fig4){ref-type="fig"} and [Figure 4---source data 4](#SD6-data){ref-type="supplementary-material"}). These cross-links revealed residues in close proximity. Ski7 was found to cross-link with Rrp4 via K111, which fits well with previous co-IP results obtained by using different fragments of Ski7 ([@bib1]) and a recently published CXMS study of the yeast exosome ([@bib65]). Among the newly identified candidate regulators, the translation initiation factor Tif1 stood out; it had interactions with the Rrp4 and Rrp44 exosome subunits ([Figure 4B](#fig4){ref-type="fig"}). Translation has been implicated in RNA quality control ([@bib66]). The linkages identified here support the hypothesis that exosome complexes 'stand by' the translation machinery and recognize and degrade aberrant mRNA molecules.

Application of Leiker to lysates {#s2-4}
--------------------------------

We further tested Leiker for the purpose of mapping protein-protein interaction networks using *E. coli* and *C. elegans* lysates. *E. coli* whole-cell lysates are commonly used for evaluating CXMS methods ([@bib57]; [@bib83]; [@bib80]). In three independent experiments, Leiker-treated, trypsin digested *E. coli* lysates were fractionated on a high pH reverse phase column, and cross-linked peptides were enriched from each of the 10 or 11 fractions ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). After filtering the data by requiring FDR \< 0.05, E-value \< 0.01, spectral count ≥ 3, we identified a total of 2003 non-redundant inter-linked lysine pairs including 1386 (69%) intra-molecular and 617 (32%) inter-molecular cross-links ([Figure 5---source data 1](#SD7-data){ref-type="supplementary-material"} and [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}). Protein structure information is available in the PDB database for 984 intra-molecular cross-links identified with Leiker, and is consistent with 80% of them, indicating the high quality of the results ([Figure 5---source data 1](#SD7-data){ref-type="supplementary-material"}). Of note, the inter-molecular cross-links represent 436 pairs of protein-protein interactions, and 25% of the cross-links are supported by the combined network of the bacteriome.org database ([@bib53]) [Figure 5---source data 1](#SD7-data){ref-type="supplementary-material"}). Most of the inter-molecular cross-links suggest novel protein-protein interactions. Based on the Leiker cross-links, we constructed a protein-protein interaction network and extracted the most highly connected module ([@bib2]; [@bib60]) ([Figure 5A](#fig5){ref-type="fig"}). This 12-protein module consists of 9 ribosomal proteins and two DNA-binding proteins (the Hu heterodimer DBHA/DBHB) organized around a translation elongation factor Tu (EF-Tu). Evidently, it is enriched with proteins that function in translation, suggesting that DBHA/DBHB also plays a role in this process. Indeed, previous studies reported that a small fraction of this Hu heterodimer is bound to ribosomes ([@bib58]) and that this protein can enhance or repress translation of the mRNA molecules that it binds to ([@bib3]). In contrast, the most connected module obtained from the previously identified BS^3^ cross-links ([@bib83]) comprised only three ribosomal proteins ([Figure 5A](#fig5){ref-type="fig"}). These results indicate the potential of Leiker in generating comprehensive protein-protein interaction networks using CXMS. Since ribosomal proteins dominated *E. coli* whole-cell lysates, we prepared samples in which ribosomes were removed by centrifugation through a layer of sucrose cushion. Analysis of the ribo-free samples (two repeats) with Leiker identified 1971 inter-links, 1127 of which were not identified in the whole-cell lysates (5% FDR, E-value \< 0.01, spectral count ≥ 3) ([Figure 5B](#fig5){ref-type="fig"}, [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}, and [Figure 5---source data 2](#SD8-data){ref-type="supplementary-material"}). Together, we identified a total of 3130 non-redundant cross-linked lysine pairs from *E. coli*. This allowed us to construct a network comprising 677 protein-protein interactions ([Figure 5---figure supplement 3A](#fig5s3){ref-type="fig"}).10.7554/eLife.12509.026Figure 5.CXMS analyses of *E. coli* and *C. elegans* lysates.(**A**) The best protein-protein interaction cluster extracted from the Leiker-identified or BS^3^-identified ([@bib83]) inter-links from *E. coli* whole-cell lysates. Node size represents the degree of connectivity of the indicated protein in the network. Line width represents the spectral counts of every inter-molecular cross-link. The line color is set to blue when the two peptides of an inter-link are both attributed to unique proteins, to grey if either could be assigned to multiple proteins. All the lines connected to EF-Tu1 are grey because EF-Tu1 differs from EF-Tu2 by only one amino acid. (**B**) Comparison of the identified inter-links in *E. coli* whole-cell lysates and ribo-free lysates (5% FDR, E-value \< 0.01, spectral count ≥ 3). (**C** and **D**) Comparison of the number of Leiker-identified inter-links and that of BS^3^-identified inter-links ([@bib83]) from *C. elegans* (**C**) and *E. coli* (**D**) whole-cell lysates (5% FDR, E-value \< 0.01, spectral count ≥ 1).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.026](10.7554/eLife.12509.026)10.7554/eLife.12509.027Figure 5---source data 1.CXMS analysis of *E. coli* whole-cell lysates.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.027](10.7554/eLife.12509.027)10.7554/eLife.12509.028Figure 5---source data 2.CXMS analysis of *E. coli* ribo-free lysates.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.028](10.7554/eLife.12509.028)10.7554/eLife.12509.029Figure 5---source data 3.CXMS analysis of *C. elegans* whole-cell lysates.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.029](10.7554/eLife.12509.029)10.7554/eLife.12509.030Figure 5---source data 4.CXMS analysis of *C. elegans* mitochondrial proteins.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.030](10.7554/eLife.12509.030)10.7554/eLife.12509.031Figure 5---figure supplement 1.Fractionation of digested, Leiker-treated *E. coli* lysates.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.031](10.7554/eLife.12509.031)10.7554/eLife.12509.032Figure 5---figure supplement 2.Overlap of cross-linked lysine pairs between biological replicates of *E. coli* lysates (FDR \< 0.05, E-value \< 0.01, and spectral count ≥ 3).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.032](10.7554/eLife.12509.032)10.7554/eLife.12509.033Figure 5---figure supplement 3.Protein-protein interaction networks constructed from the cross-links identified in (**A**) *E. coli* and (**B**) *C. elegans*.The labeling scheme is the same as described in [Figure 5A](#fig5){ref-type="fig"} except for the node color. For *E. coli*, node color is set to orange if the protein was only identified in the whole-cell lysates, to yellow only identified in the ribo-free lysates, or to green if identified in both. There are 626 proteins in the *E. coli* network and 155 proteins in the *C. elegans* network.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.033](10.7554/eLife.12509.033)

Applying Leiker to an even more complex lysate from *C. elegans*, which has a similar number of protein coding genes as human (\~20,000), we identified 459 inter-links (5% FDR, E-value \< 0.01, spectral count ≥ 3) ([Figure 5---source data 3](#SD9-data){ref-type="supplementary-material"}). We also analyzed a *C. elegans* mitochondrial fraction and identified 547 inter-linked lysine pairs (5% FDR, E-value \< 0.01, spectral count ≥ 3), of which 434 were not detected in the whole-worm lysate ([Figure 5---source data 4](#SD10-data){ref-type="supplementary-material"}). Together, we identified 893 non-redundant cross-linked lysine pairs from *C. elegans* and constructed protein-protein interactions between 155 proteins ([Figure 5---figure supplement 3B](#fig5s3){ref-type="fig"}).

In order to compare with previous studies, we also applied a less stringent cutoff (5% FDR, E-value \< 0.01, spectral count ≥ 1) to the data sets of *E. coli* and *C. elegans* whole-cell lysates. This allowed us to determine that the number of *C. elegans* cross-links identified in this study was 23 times as many as the previous record ([Figure 5C](#fig5){ref-type="fig"}) ([@bib83]). The number of *E. coli* cross-links identified in this study is four times greater than the number of PIR-identified inter-links ([@bib9]) and eight times greater than the number of BS^3^-identified inter-links ([@bib83]). Half of the BS^3^-identified cross-links ([@bib83]) were recapitulated in this study ([Figure 5D](#fig5){ref-type="fig"}).

Leiker-based quantitative CXMS analysis {#s2-5}
---------------------------------------

Relative quantification of cross-linker modified peptides can reveal changes in protein conformation and/or interactions between a protein and another molecule (e.g. nucleic acid, ligand, or protein). To apply Leiker in quantitative CXMS, we synthesized deuterium-labeled Leiker (\[d~6~\]-bAL2) in addition to the unlabeled version (\[d~0~\]-bAL2). Few software tools reported to date directly support quantitative CXMS ([@bib16]; [@bib78]). We therefore modified the quantification software pQuant ([@bib41]) and established an automated data analysis workflow for quantitative CXMS ([Figure 6](#fig6){ref-type="fig"} and Materials and methods). As a proof-of-principle experiment, we compared the RNA-free and H/ACA RNA-bound states of a *Pyrococcus furiosus* ribosomal protein L7Ae ([@bib59]; [@bib38]). We treated RNA-free L7Ae with \[d~0~\]-bAL2 and the assembled L7Ae-RNA complex with \[d~6~\]-bAL2 in the forward reaction, and switched the isotope labels in the reverse reaction ([Figure 7A](#fig7){ref-type="fig"}). An equal amount of BSA protein was included in each sample to control for possible difference in cross-linking efficiency between \[d~0~\]- and \[d~6~\]-Leiker. We expected that the formation of the protein-RNA complex would block the access of Leiker to lysine residues at the binding interface, which would be manifested as large abundance decrease of mono- or inter-linked peptides at these sites.10.7554/eLife.12509.034Figure 6.Workflow for quantification of cross-linked peptides using pQuant.For each identified cross-link spectrum, an extracted ion chromatogram (EIC) is constructed for each isotopic peak of the \[d~0~\]- and \[d~6~\]-labeled precursor. The \[d~6~\]/\[d~0~\] ratios can be calculated based on the monoisotopic peak, the most intense peak, or the least interfered peak of each isotopic cluster as specified by users. The accuracy of the ratio calculation was evaluated with the confidence score σ (range: 0--1, from the most to the least reliable). If a cross-link have ratios with σ \< 0.5, the median of these ratios is assigned to this cross-link. The cross-link ratios of the proteins of interest are normalized to the median ratio of all BSA cross-links. For each cross-link, the median \[state1\]/\[state2\] ratio of three independent forward labeling experiments is plotted against the median ratio of three independent reverse labeling experiments. Cross-links that are only present in state1 or state2 due to a dramatic conformational change cannot be quantified as described above because the ratios would be zero or infinite and their σ values would be 1. Therefore, if a cross-link does not have a valid ratio after automatic quantification, the EICs were manually inspected to determine if it was an all-or-none change.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.034](10.7554/eLife.12509.034)10.7554/eLife.12509.035Figure 7.Quantitative CXMS analysis of the L7Ae-RNA complex.(**A**) Reciprocal labeling of RNA-free (**F**) and RNA-bound (**B**) L7Ae with \[d~0~\]/\[d~6~\]-Leiker. (**B**) Abundance ratios of mono-links (F/B) in the forward (F^\[d0\]^/B^\[d6\]^) and the reverse labeling experiment (F^\[d6\]^/B^\[d0\]^). Each circle represents a mono-linked lysine residue and is colored red if it has a ratio greater than five in both labeling schemes. (**C**) The three lysine residues affected by RNA binding are highlighted in the structure model (PDB code: 2HVY). The number below each such lysine residue indicates the buried surface area (Å^2^) upon RNA binding. (**D**) Extracted ion chromatograms (left) and representative MS1 spectra (right) of a K42 mono-link.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.035](10.7554/eLife.12509.035)10.7554/eLife.12509.036Figure 7---source data 1.Quantitative CXMS analysis of L7Ae with or without the H/ACA RNA.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.036](10.7554/eLife.12509.036)10.7554/eLife.12509.037Figure 7---figure supplement 1.Extracted ion chromatograms (left) and representative MS1 spectra (right) of a mono-linked peptide corresponding to (**A**) K35 and (**B**) K84.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.037](10.7554/eLife.12509.037)

Mono-linked peptides are usually neglected in CXMS, but they are valuable because they indicate that the modified lysine residues are exposed to solvent. Mono-links at all 15 lysine residues and the N-terminus of L7Ae were reliably quantified ([Figure 6](#fig6){ref-type="fig"}) in both forward and reverse labeling experiments. Three mono-links at K35, K42, and K84 consistently had significantly higher abundance (\>5 fold) in the RNA-free state (F) than in the RNA-bound state (B) ([Figure 7B--D](#fig7){ref-type="fig"}, [Figure 7---figure supplement 1](#fig7s1){ref-type="fig"} and [Figure 7---source data 1](#SD11-data){ref-type="supplementary-material"}). None of inter-links passed the quantification criteria described above. These results suggest that the three lysine residues are buried upon RNA binding, either due to direct protein-RNA binding or indirect protein conformational changes induced by RNA binding. This is in perfect agreement with the crystal structure ([@bib38]) (PDB code: 2HVY), which shows that K35, K42, and K84 all bind to the RNA, each with a buried area greater than 20 Å^2^ ([Figure 7C](#fig7){ref-type="fig"}).

Lastly, we applied quantitative CXMS to *E. coli* lysates. The log phase and the stationary phase cell lysates were cross-linked, respectively, with \[d~0~\]- and \[d~6~\]-bAL2 in the forward labeling experiment, or with \[d~6~\]- and \[d~0~\]-bAL2 in the reverse labeling experiment. After a single enrichment step without pre-fractionation, a total of 161 inter-linked lysine pairs were quantified in both the forward and the reverse labeling experiments, and most of them had similar \[log phase\]/\[stationary phase\] ratios in the two experiments ([Figure 8](#fig8){ref-type="fig"} and [Figure 8---source data 1](#SD12-data){ref-type="supplementary-material"}). Noticeably, the cross-link between YqjD and ElaB increased at least 10 times in the stationary phase compared to the log phase. These two paralogous proteins are associated with the inner membrane of *E. coli* cells through their C-terminal transmembrane motifs and both bind to stationary phase ribosomes, probably through their N-terminal regions ([@bib85]). It is suggested that YqjD binding to ribosomes inhibits translation ([@bib85]). Association of YqjD and ElaB has been detected but the sites of interaction are not known ([@bib22]). Here, our results not only confirm previous findings, but also provide new insights that YqjD and ElaB form a heterodimer through their central regions, presumably as a stronger, divalent anchoring site for ribosomes to inhibit protein translation in the stationary phase.10.7554/eLife.12509.038Figure 8.Quantitative CXMS analysis of *E. coli* lysates.Abundance ratios of (**A**) inter-linked lysine pairs and (**B**) mono-linked sites in the forward (\[log phase\]^d0^/\[stationary phase\]^d6^) and the reverse labeling experiment (\[log phase\]^d6^/\[stationary phase\]^d0^).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.038](10.7554/eLife.12509.038)10.7554/eLife.12509.039Figure 8---source data 1.Quantitative CXMS analysis of *E. coli* lysates.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.039](10.7554/eLife.12509.039)

Discussion {#s3}
==========

In this study, we developed an MS-friendly and isotope-encodable cross-linker called Leiker that enables the efficient enrichment of cross-linked peptides through biotin-based immobilization and azobenzene-based chemical cleavage. With an enrichment efficiency of 97% or more, Leiker yields a fourfold increase in the number of identified cross-linked peptide pairs from complex samples. Also established is a workflow for quantitative CXMS based on deuterium-labeled Leiker.

In theory, a comprehensive network of putative direct protein-protein interactions could be obtained by applying Leiker to lysates. However, the interaction networks obtained as such are limited, because the cross-links identified are dominated by those from highly abundant proteins, for example, EF-Tu and ribosomal proteins in *E. coli*. This can be overcome with subcellular fractionation, which can separate abundant proteins from less abundant ones. We increased the number of unique inter-link identifications by more than 50% (from 2003 to 3130) by simply removing ribosomes from the *E. coli* lysates ([Figure 5B](#fig5){ref-type="fig"}). This is also obvious by contrasting the CXMS results of the whole-worm lysate and the mitochondrial fraction of *C. elegans*, from which 459 and 547 inter-linked lysine pairs were detected, respectively, with an overlap of only 113. We anticipate that extensive protein fractionation coupled with Leiker-assisted CXMS will pave the way towards constructing comprehensive interactomes for different model organisms, and next-generation cross-link identification software of higher sensitivity will also help. Further, with the advantage of heavy isotope labeling for quantification in addition to the enrichment function, Leiker shows promise for use in differential interactome analysis ([@bib23]).

When we examined the cross-links identified from *E. coli* against the protein structures deposited in the PDB database, we noted that the intra-molecular cross-links in both the whole-cell lysates and the ribo-free samples had similar rates of structural compatibility (80% and 84%, respectively). This shows that the quality of our Leiker-based CXMS data is high. Interestingly, the inter-molecular cross-links detected from the ribo-free samples had a much higher rate of structural compatibility (69%) than those detected in the whole-cell lysates (12%). Given that 92% of the inter-links with existing structural information in the whole-cell lysate involved at least one ribosomal protein and many were between ribosomal proteins, we think that most of the apparently incompatible inter-molecular cross-links seen in the whole-cell lysates likely result from cross-linking of adjacent ribosomal particles.

Previous cross-linking studies have typically treated mono-linked peptides as by-products, and have ignored them. This is regrettable, as they carry structural information about proteins and always outnumber inter-links ([Figure 3](#fig3){ref-type="fig"}). Leiker also generates abundant mono-links. In this study, we demonstrate that mono-links are highly valuable in mapping RNA-binding lysine residues. As the positively charged lysine residue is frequently involved in binding the negatively charged phosphate backbone of DNA and RNA, relative quantification of lysine mono-links would be particularly suited for mapping the DNA or RNA binding surface on a protein. We suggest that mono-link data should be used in routine practice.

Materials and methods {#s4}
=====================

Materials {#s4-1}
---------

Acetonitrile, methanol, formic acid, ammonium bicarbonate, and acetone were purchased from J.T. Baker (Center Valley, PA). Dimethylsulfoxide (DMSO), HEPES, urea, thiourea, and other general chemicals were purchased from Sigma-Aldrich (St. Louis, MO). Trypsin and Lys-C were purchased from Promega (Wisconsin, WI). Bis(sulfosuccinimidyl) suberate (BS^3^), streptavidin agarose resin, and high capacity streptavidin agarose resin were purchased from Pierce (Rockford, IL). Dynabeads M-280 streptavidin was purchased from Invitrogen (Carlsbad, CA).

Preparation of protein samples {#s4-2}
------------------------------

RNase A, lysozyme, aldolase, BSA, lactoferrin, β-galactosidase, and myosin were obtained from Sigma-Aldrich. Recombinant GST containing an N-terminal His tag was expressed in *E. coli* BL21 cells from the pDYH24 plasmid and purified with glutathione sepharose (GE Healthcare, Piscataway, NJ). PUD-1/PUD-2 heterodimers were purified on a HisTrap column followed by gel filtration. Stock solutions of the ten standard proteins were individually buffer exchanged into 20 mM HEPES, pH8.0 by ultrafiltration, and then mixed to make a total protein mixture with a 2 µg/µl protein concentration.

Purification of 70S ribosomes from *E. coli* cells was performed as previously described ([@bib19]). *E. coli* cells (DH5α) were grown in 2 L LB medium to an OD~600~=0.8. Cells were collected by centrifugation, washed with 100 mL lysis buffer (50 mM HEPES-KOH, pH 7.5, 500 mM KCl, 12 mM MgCl~2~, 1 mM DTT, 1 mM PMSF) and resuspended in 100 mL of lysis buffer. Cells were then disrupted with an Ultrasonic Cell Disruptor. The lysate was clarified at 13,000 rpm for 1 hr at 4°C in a JA 25.50 motor (Beckman Coulter, UK). The supernatant was layered on a sucrose cushion (50 mM HEPES-KOH, pH 7.5, 500 mM KCl, 12 mM MgCl~2~, 33% sucrose) and centrifuged at 30,000 rpm for 18 hr in a 70Ti rotor (Beckman Coulter) at 4°C. The supernatant was collected as the ribo-free lysate. The pellet was resolved with a buffer containing 50 mM HEPES-KOH, pH 7.5, 500 mM KCl, and 12 mM MgCl~2~. The crude ribosomes were then layered on a 10--50% sucrose gradient (50 mM HEPES-KOH, pH 7.5, 500 mM KCl, 12 mM MgCl~2~, 10% to 50% sucrose) and centrifuged at 28,000 rpm for 5 hr in an SW28 rotor (Beckman Coulter) at 4°C. The gradient was scanned at 260 nm and fractionated in an ISCO gradient collector. The fractions of 70S ribosomes were pooled and concentrated with Amicon Ultra centrifugation filters (Millipore, China) with a buffer containing 50 mM HEPES-KOH, pH 7.5, 500 mM KCl, and 12 mM MgCl~2~.

The yeast exosome complex was immunoprecipitated with IgG beads as described previously ([@bib41]), with the following modifications: a gentle wash buffer (150 mM NaCl) was applied and the mono-Q anion exchange step was not performed. These modifications were made in order to maintain the interaction of the proteins in the sample. Eluted proteins were exchanged into 20 mM HEPES, pH 8.0, 150 mM NaCl.

*E. coli* OP50 lysates and *C. elegans* N2 lysates were prepared following a protocol from Bing *et al.* ([@bib83]; [@bib87]). Mitochondria were isolated from the wild-type N2 worms as described previously ([@bib64]) and lysed by incubation in 100 mM HEPES pH 8.0, 1% NP-40, 10 mM CaCl~2~ at 4°C for 30 min.

The *Pyrococcus furiosus* L7Ae and the H/ACA RNA were prepared as described previously ([@bib38]). The buffer was exchanged to 50 mM HEPES, pH 7.6, 1 M NaCl.

*E. coli* (MG1665) cells were grown at 37°C in 500 mL M9 minimal medium from a 1 mL overnight culture. Log phase cells were harvested after 11 hr at OD~600~ 0.7; stationary phase cells were harvested after 26 hr at OD~600~ 2.3. Cell lysates were prepared in 50 mM HEPES pH 8.0, 150 mM NaCl using a FastPrep system (MP Biomedicals, Santa Ana, CA) using two volumes of glass beads at 6.5 m/s, 20 s per pulse for four pulses, with 5 min of cooling on ice between pulses. The lysates were cleared by centrifugation at top speed in a tabletop microfuge for 30 min. Protein concentrations were determined using the bicinchoninic acid assay.

Trypsin digestion {#s4-3}
-----------------

At room temperate (RT), protein pellets were dissolved (assisted by sonication) in 8 M urea, 20 mM methylamine (to reduce carbamylation), 100 mM Tris, pH 8.5, reduced with 5 mM TCEP for 20 min and alkylated with 10 mM iodoacetamide for 15 min in the dark. Then, the samples were diluted with 3 volumes of 100 mM Tris, pH 8.5 and digested with trypsin at 1/50 (w/w) enzyme/substrate ratio at 37°C for 16--18 hr.

CXMS analysis of model proteins {#s4-4}
-------------------------------

The optimal protein-to-cross-linker mass ratio was determined by a titration experiment. 1 µl of cross-linker at increasing concentrations (2.5 µg/µl, 5 µg/µl, 10 µg/µl, 20 µg/µl, 40 µg/µl) in DMSO was incubated with 20 µl of 2 µg/µl of the ten-protein mixture at RT for 1 hr to make 16:1, 8:1, 4:1, 2:1, and 1:1 protein-to-cross-linker mass ratios, respectively. The reactions were quenched with 20 mM NH~4~HCO~3~ at RT for 20 min. Cross-linking products were analyzed by SDS-PAGE. The 4:1 ratio was ultimately chosen for both the one-piece and the two-piece Leiker. Higher dosages were avoided to minimize excessive cross-linking.

For comparison of the one-piece and two-piece Leikers, 50 µl of the 2 µg/µl ten-protein mixture was incubated with 0.5 µl of 50 µg/µl AL or bAL1 at RT for 1 hr. The reactions were quenched as described above. For AL, the solution was mixed with 350 µl of 8 M urea, 100 mM Tris, pH 8.5, and filtered with an Amicon Ultra-0.5 10-kD filter device (Millipore). Excess cross-linker molecules were removed by two additional washes with urea. Click chemistry was subsequently performed on the membrane. In a 100 µl reaction, 28 nmol of azide-biotin was added (an amount equal to the starting amount of the alkyne group of AL), followed by the addition of 2 mM CuSO~4~, 2 mM TCEP, and 200 µM TBTA. Samples were gently rotated and incubated at RT for 2 hr. The excess free azide-biotin was then removed by washes with urea in the filter device. Finally, the proteins were collected by centrifugation with the filter device placed upside down inside the tube. Recovered proteins were transferred to a new 1.5 mL tube, precipitated at -20°C with four volumes of pre-cooled acetone for at least 30 min, and digested with trypsin. The bAL1 samples were processed in the same way except that the reaction mixture was precipitated directly without going through the 10-kD filter device.

The AL- and bAL1-cross-linked peptides were enriched in parallel. The tryptic digests, without formic acid (FA) acidification, were directly mixed with an equal volume of 20 mM HEPES, pH 8.0 and incubated with 40 µl pre-washed high capacity streptavidin agarose for 2 hr. Then, the beads were washed three times with 20 mM HEPES, pH 8.0, 1 M KCl, once with H~2~O, three times with 10% acetonitrile (ACN), and another three times with H~2~O, each time with 1 mL buffer or H~2~O, with 5-min rotation. Supernatants were removed carefully with a 1 mL syringe needle connected to a vacuum pump. Loss of beads was avoided by keeping the beveled surface of the needle tip in contact with the wall of the tube. After the extensive washes, the peptides were released by incubating the beads with 5× bed volumes of cleavage buffer (300 mM Na~2~S~2~O~4~ in 6 M urea, 2 M thiourea, 10 mM HEPES, pH8.2) ([@bib84]) at 37°C for 30 min, with end-to-end rotation. Recovered peptides were acidified with 5% FA and subsequently desalted on home-made C18 desalting columns, followed by elution with 70% ACN/0.1% FA. Eluates were vacuum dried and reconstituted in 0.1% FA for mass spectrometry analyses. The color of the beads could be used to monitor the entire enrichment process: a bright yellow color indicated the binding of Leiker-linked peptides; a return to a white color occurred when the cleavage reaction was successful.

Comparison of bAL1 and bAL2 was carried out in two samples. For the first comparison, 50 µg of the ten-protein mixture was cross-linked with bAL1 or bAL2 at 4:1 protein-to-cross-linker mass ratio and then digested with trypsin. After mixing with the tryptic digest of an *E. coli* lysate containing 500 µg of total proteins, the digested Leiker-linked peptides were affinity purified with 20 µl of high-capacity streptavidin agarose. For the second comparison, 30 µg of ribosome was treated with bAL1 or bAL2 at 8:1, 4:1, or 2:1 protein-to-cross-linker mass ratios, digested, and enriched using 20 µl of high-capacity streptavidin agarose.

For the serial dilution experiment ([Figure 3](#fig3){ref-type="fig"}), 200 µg of the ten-protein mixture was treated with 50 µg of bAL1 at RT for 1 hr. After quenching, the proteins were precipitated and digested with trypsin. Four equal aliquots of this digest were either not diluted to serve as a control (1:0) or diluted with the tryptic digest of a non-cross-linked *E. coli* lysate at 1:1, 1:10, or 1:100 (w/w) ratio. Each mixture was enriched with 200 µl of pre-washed streptavidin agarose.

CXMS analysis of purified ribosomes and the immunoprecipitated exosome complex {#s4-5}
------------------------------------------------------------------------------

30 µg of ribosome was treated with bAL2 at 8:1, 4:1, or 2:1 protein-to-cross-linker mass ratios. 40 µl of the exosome complex sample (1 µg/µl) was incubated with 0.25 µl of 40 µg/µl bAL2 at RT for 1 hr. 20 µl of high-capacity streptavidin agarose was used to enrich Leiker-linked peptides in each sample.

Negative staining of *E. coli* 70S ribosome {#s4-6}
-------------------------------------------

70S ribosomes were negatively stained with 0.2% uranyl acetate. Carbon coated grids were first glow-discharged to increase the surface hydrophilicity using a Harrick Plasma cleaner. 4 µL aliquots of 70S ribosomes (\~10 nM) were placed on grids for about 1 min, and excessive liquid was absorbed by filter paper. After that 0.2% uranyl acetate was applied on the grid for about 1 min and absorbed using filter paper. The grids were air-dried and examined using an FEI Tecnai Spirit BioTwin microscope (FEI, Hillsboro, OR) (120 KV) at 49,000× magnification.

CXMS analysis of *E. coli* and *C. elegans* cell lysates {#s4-7}
--------------------------------------------------------

*E. coli* or *C. elegans* lysates prepared as described previously ([@bib83]; [@bib87]) (1 mg of total proteins) were treated with 250 µg bAL1 at RT for 1 hr, in 300 µl reactions; NH~4~HCO~3~ was added to quench the reactions. Proteins were precipitated and digested with trypsin. After centrifugation in a bench top centrifuge at top speed for 30 min and filtering with a 50-kD cutoff filter, the digested peptides were brought to a volume of 3 mL with 2% ACN, 20 mM HEPES, pH 8.2; the pH was adjusted to 10.0 with ammonia prior to high-pH reverse phase separation on an Xtimate column (10×250 mm) packed with 5 μm C18 resin (Welch Materials, China) at a flow rate of 2 mL/min. A 70 min gradient was applied as follows: 0-6% B in 10 min, 6-40% B in 40 min, 40-100% B in 10 min, 100% B for 10 min (A = 4% ACN, 5 mM NH~4~COOH, pH 10, B = 80% ACN, 5 mM NH~4~COOH, pH 10). A total of 39 two-min fractions were collected, and then combined into 9--11 fractions of similar shades of color judging by naked eyes. These pooled samples were evaporated to 200--300 µl volumes before Leiker-linked peptides were enriched with 50 µl of high-capacity streptavidin beads from each sample. For the ribo-free lysates, 3 mg of proteins were cross-linked with 0.75 mg bAL2 at RT for 1 hr, and subjected to tryptic digestion and fractionation as described above.

*C. elegans* mitochondria were prepared as described previously ([@bib64]), and the CXMS analysis was performed as described above except with two differences: 3.2 mg of total proteins was used as the starting material and the collected fractions were pooled into 5 fractions.

Quantitative CXMS analysis of the L7Ae-RNA complex {#s4-8}
--------------------------------------------------

In the forward and reverse labeling experiments, 0.7 nmol of RNA-free L7Ae was treated with \[d~0~\]-bAL2 and \[d~6~\]-bAL2, respectively; an equal amount of L7Ae was pre-incubated with 1 nmol of the 65 nt H/ACA RNA at 4°C for 30 min and then treated with \[d~6~\]-bAL2 and \[d~0~\]-bAL2, respectively. An equal amount of BSA was spiked into each cross-linking reaction. A 4:1 protein-to-cross-linker ratio (w/w) was used for each reaction. The cross-linking reactions were quenched with ammonium bicarbonate after 1 hr at RT. The paired \[d~0~\]- and \[d~6~\]-bAL2 samples were combined and subjected to acetone precipitation and trypsin digestion.

Quantitative CXMS analysis of *E. coli* lysates {#s4-9}
-----------------------------------------------

In the forward labeling experiment, the log phase and the stationary phase cell lysates (100 µg proteins each) were cross-linked with 50 µg of \[d~0~\]-bAL2 and 50 µg of \[d~6~\]-bAL2, respectively, with 1 µg of BSA spiked into each sample. After 1 hr at RT, the two reactions were quenched, mixed, precipitated with acetone, and digested with trypsin. The reverse labeling experiment was conducted in the same way except that the log phase lysate was cross-linked with \[d~6~\]-bAL2 and the stationary phase lysate was cross-linked with \[d~0~\]-bAL2.

LC-MS/MS analysis {#s4-10}
-----------------

All protein samples were analyzed with an EASY-nLC 1000 system (Thermo Fisher Scientific, Waltham, MA) interfaced with a Q-Exactive mass spectrometer (Thermo Fisher Scientific). A two-column setup was used, consisting of a pre-column (100 μm×4 cm, 3 μm C18) with a frit at each end and an analytical column (75 μm×10 cm, 1.8 μm C18) with a 5 µm tip. For the Leiker-cross-linked samples after enrichment, typically one third of a reconstituted sample was injected and separated with a 65 min linear gradient at a flow rate of 300 nl/min as follows: 0--5% B in 2 min, 5--28% B in 41 min, 28--80% in 10 min, 80% for 12 min (A = 0.1% FA, B = 100% ACN, 0.1% FA). Slight modifications to the separation method were made for different samples. A 120 min gradient was used with a more gradual ramp to 28% buffer B. The Q-Exactive mass spectrometer was operated in data-dependent mode with one full MS scan at R = 70000 (m/z = 200), followed by ten HCD MS/MS scans at R = 17,500 (m/z = 200), NCE = 27, with an isolation width of 2 m/z. The AGC targets for the MS1 and MS2 scans were 3e6 and 1e5, respectively, and the maximum injection times for MS1 and MS2 were both 60 ms. For cross-linked samples, precursors of the +1, +2, +7 or above, or unassigned charge states were rejected; exclusion of isotopes was disabled; dynamic exclusion was set to 30 s.

For accurate mass analysis, 20 µg/ml of \[d~0~\]-bAL2 or \[d~6~\]-bAL2 in methanol was sprayed directly into a LTQ Orbitrap XL mass spectrometer (Thermo Fisher Scientific) operated in the negative mode with a spray voltage of 0.8 kV and a scan mass range of 150--1000 m/z.

Identification of cross-linked peptides with pLink {#s4-11}
--------------------------------------------------

The Xcalibur raw data was converted to ms2 files using RawExtract ([@bib46]). Cross-linked peptides were identified using pLink software as described previously ([@bib83]), with the following modifications Cross-linker was set to AL, bAL1, bAL2, \[d~6~\]-bAL2, or BS^3^; The minimum peptide length was 5 amino acids for lysate samples; oxidation on Met was set as a variable modification.

For the ten-protein mixture and ribosome complexes, the search databases consisted of the sequences of all of the proteins in question. The sequences were downloaded from NCBI or Uniprot.

Prior to the CXMS analysis of the exosome complex, LC-MS/MS analyses of digested, uncross-linked samples were carried out to identify the proteins present in the samples. For protein identification, the precursors of +1 or unassigned charge states were rejected; MS2 spectra were searched against a *S. cerevisiae* protein database (downloaded from Uniprot on 2013-04-03) using ProLuCID2 ([@bib81]) and filtered using DTASelect 2.0 ([@bib71]) with a spectral false identification rate ≤1% and a minimum of two identified peptides for each protein. A restricted database containing only the identified proteins (740 in total) was generated using Contrast 2.0 ([@bib71]). MS2 spectra from the cross-linked samples were then searched against this small database using pLink.

For the CXMS analysis of *E. coli* whole-cell lysates and ribo-free lysates, the sequences of the entire proteome of the K12 strain were downloaded from Uniprot on 2014-07-31 and used for searching.

For the CXMS analysis of *C. elegans* lysates, a database consisting of proteins identified from N2 *C. elegans* lysates generated with ProLuCID2 was used for searching (unpublished).

For the CXMS analysis of *C. elegans* mitochondrial proteins, a restricted database was constructed in a similar way as for the exosome complex.

Quantification of cross-linked peptides with pQuant {#s4-12}
---------------------------------------------------

pQuant ([@bib41]) was used to determine the heavy-to-light ratio (H/L) of each cross-link. The regression model **Y** = *a***X** +*e* is used to calculate peptide ratios. The optimal value of *a* is solved using the least-squares method as $\hat{a} = \sum^{}X_{j}Y_{j}/\sum^{}X_{j}X_{j}$, and the estimated standard error of $\hat{a}$ is $\hat{\sigma} = \left( K^{- 1} \bullet \sum^{}\left( Y_{j} - \hat{a}X_{j} \right)^{2}/\sum^{}X_{j}{}^{2} \right)^{1/2}$. is then normalized to the interval of \[0,1\], and is named confidence score. If the value of $\hat{\sigma}$ is zero (the highest confidence), there is no interference signal; if the value is one (the lowest confidence), the peptide signals are inundated by interference signals. For each identified cross-link spectrum, an extracted ion chromatogram (EIC) was constructed for each isotopic peak of the light- and heavy-labeled precursor. The H/L ratios can be calculated based on the monoisotopic peak, the most intense peak, or the least interfered peak of each isotopic cluster as specified by users. For L7Ae, all options yielded similar results and we selected the monoisotopic peak. For the highly complex samples of the log phase versus stationary phase *E. coli*, the option of the least interfered peak performed the best. For each cross-link, every identified spectrum (E-value \< 0.001) will lead to a H/L ratio and a confidence score σ, because pQuant conducts the quantitation independently starting from each identified MS/MS spectrum. In most cases, the H/L ratios obtained for the same precursor ion are close, but sometimes the ratios may differ due to multiple reasons including local interference signals or a sudden decrease followed by recovery in signal intensity in the chromatograms, all of which can affect the calling of the start and the end of a chromatogram peak. Ratios with σ values above or equal to 0.5 were discarded. The median H/L ratio obtained from the remaining spectra was assigned to a cross-linked lysine pair or a mono-linked lysine residue as the final quantification value. If a cross-link had no assigned ratio value (i.e., none of its ratios had a σ value less than 0.5), we manually evaluated the reconstructed ion chromatograms to assess abundance changes. All the ratios were normalized against the median value of all the H/L ratios belonging to the spiked-in BSA.
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Synthesis of Leiker molecules {#s23}
=============================

Instrumentation and methods {#s24}
---------------------------

^1^H NMR spectra were recorded on a Varian 400 MHz spectrometer at ambient temperature with CDCl~3~ as the solvent unless otherwise stated. ^13^C NMR spectra were recorded on a Varian 100 MHz spectrometer (with complete proton decoupling) at ambient temperature. Chemical shifts are reported in parts per million relative to chloroform (^1^H, δ 7.26; ^13^C, δ 77.00). Data for ^1^H NMR are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), integration and coupling constants. Infrared spectra were recorded on a Thermo Fisher FT-IR200 spectrophotometer. High-resolution mass spectra were obtained at Peking University Mass Spectrometry Laboratory using a Bruker APEX Flash chromatography. The samples were analyzed by HPLC/MS on a Waters Auto Purification LC/MS system (3100 Mass Detector, 2545 Binary Gradient Module, 2767 Sample Manager, and 2998 Photodiode Array (PDA) Detector). The system was equipped with a Waters C18 5μm SunFire separation column (150\*4.6 mm), equilibrated with HPLC grade water (solvent A) and HPLC grade acetonitrile (solvent B) with a flow rate of 0.3 mL/min. Flash chromatography was performed using 200-400 mesh silica gel. Yields refer to chromatographically and spectroscopically pure materials, unless otherwise stated.

Reagents and solvents {#s25}
---------------------

All chemical reagents were used as supplied by Sigma-Aldrich, J&K and Alfa Aesar Chemicals. DCM, DMF, DMSO were distilled from calcium hydride; tetrahydrofuran was distilled from sodium/benzophenone ketyl prior to use. 4-(2-carboxyethyl) heptanedioic acid **1** ([@bib50]; [@bib31]), 1-(5-methoxy-2-nitro-4-(prop-2-yn-1-yloxy) phenyl)ethanol N-(3-azidopropyl)-5-(2- oxohexahydro-1H-thieno\[3,4-d\]imidazol-4-yl)pentanamide **4** ([@bib27]), 4-(prop-2-yn-1-yloxy)aniline **9** ([@bib42]), tert-butyl 3-hydroxybenzyl carbamate **10** ([@bib51]), **14** ([@bib79]),(9H-fluoren-9-yl)methyl (3-hydroxy propyl)carbamate **19** ([@bib14]), biotin pentafluorophenyl ester **24** ([@bib32]), were prepared according to the literature reported procedures. All reactions were carried out in oven-dried glassware under an argon atmosphere unless otherwise noted.

Synthetic procedures {#s26}
====================

![Synthesis of sulfo-Photo-cleavable Leiker (sulfo-PL, 8)\
**DOI:** [http://dx.doi.org/10.7554/eLife.12509.040](10.7554/eLife.12509.040)](elife-12509-app1-fig1){#fig9}

Reagents and conditions: (a) **2**, EDCI, DMSO, 24 h; (b) **5**, EDCI, DMAP, DCM, 12 h, 93%; (c) TFA/DCM, 2.5 h; (d) **3**, TEA, DMSO, 24 h, 56% for two steps.10.7554/eLife.12509.041Appendix 1---figure 2.Compound 3.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.041](10.7554/eLife.12509.041)

Compound **3**: To a solution of triacid **1** (23.2 mg, 0.1 mmol) in anhydrous DMSO (5 mL) was added **2** (71.6 mg, 0.33 mmol) and EDCI (67.1 mg, 0.35 mmol). The reaction was stirred at room temperature for 24 h. After that, 40 mL of anhydrous THF was added, and the solution became muddy. The solvents were poured out after standing overnight to give the crude product **3**, which was directly used for the next step.10.7554/eLife.12509.042Appendix 1---figure 3.Compound 6.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.042](10.7554/eLife.12509.042)

Compound **6**: To a solution of alcohol **4** (48.5 mg, 0.193 mmol) in DCM (2.5 mL) was added acid **5** (67.6 mg, 0.386 mmol), EDCI (74 mg, 0.386 mmol) and DMAP (0.7 mg, 0.0058 mmol). The reaction was stirred at room temperature for 12 h. H~2~O (5 mL) was added and the mixture was extracted with CH~2~Cl~2~ (10 mL×3). The combined organic layers were washed with brine (5 mL). After dried over Na~2~SO~4~, the solution was concentrated *in vacuo* and purified by flash chromatography (silica gel, 30% EtOAc in petrol ether) to afford the desired compound **6** as a waxy solid (75.7 mg, 93%): ^1^H NMR (400 MHz CDCl~3~): δ 1.41 (s, 9H), 1.62 (d, *J* = 6.4 Hz, 3H), 2.58 (m, 3H), 3.38 (m, 2H), 3.97 (s, 3H), 4.82 (d, *J* = 2.4 Hz, 2H), 4.95 (br, 1H), 6.51 (q, *J* = 6.4 Hz, 1H), 7.03 (s, H), 7.75 (s, 1H); ^13^C NMR (100 MHz CDCl~3~): δ 22.0, 28.3, 34.7, 36.0, 56.4, 56.9, 68.5, 77.0, 77.1, 79.4, 108.4, 110.2, 133.8, 139.6, 145.6, 154.1, 155.8, 171.2; IR (neat) ν~max~ 3291, 2978, 1710, 1519, 1336, 1276, 1209, 1168, 1018, 791 cm^-1^; HRMS (ESI): \[M+Na\]^+^ calculated for C~20~H~26~N~2~NaO~8~: 445.1581, found: 445.1585.10.7554/eLife.12509.043Appendix 1---figure 4.Compound 7.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.043](10.7554/eLife.12509.043)

Compound **7**: To a solution of compound **6** (22.4 mg, 0.053 mmol) in DCM (2 mL) was added TFA (0.5 mL). The resulting mixture was stirred at room temperature for 2.5 h. The solvents were removed *in vacuo* to afford the crude product **7**, which was directly used for the next step.10.7554/eLife.12509.044Appendix 1---figure 5.Compound 8.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.044](10.7554/eLife.12509.044)

Compound **8**: To a solution of the crude product **3** (freshly prepared from 23.2 mg of triacid **1**) in DMSO (2 mL) was added compound **7** (freshly prepared from 22.4 mg of compound **6**) dissolved in DMSO (0.5 mL). Triethylamine (50 μL, 0.36 mmol) was added to the solution subsequently. The reaction was stirred at room temperature for 24 h. DMSO was removed by using the genevac HT-4X evaporator and the product was isolated by HPLC (20-40% CH~3~CN in water over 18 min). CH~3~CN was removed *in vacuo* and water was removed by using Christ ALPHA 1-4 LD plus to yield a white solid (26.7 mg, 56% for two steps): mp=142-145 °C; ^1^H NMR (400 MHz DMSO): δ 1.48 (m, 3H), 1.58 (m, 7H), 2.01 (m, 2H), 2.64 (m,4H), 2.85 (m, 2H), 3.24 (m, 2H), 3.65 (t, *J* = 2.4 Hz, 1H), 3.94 (s, 5H), 4.93 (d, *J* = 2.4 Hz, 2H), 6.22 (q, *J* = 6.4 Hz, 1H), 7.14 (s, H), 7.69 (s, 1H), 7.94 (t, *J* = 5.6 Hz, 1H); ^13^C NMR (100 MHz DMSO): δ 15.6, 21.4, 25.5, 27.1, 27.6, 30.9, 32.1, 33.9, 34.2, 34.5, 35.3, 36.1, 42.3, 54.6, 56.3, 56.4, 67.5, 78.4, 79.2, 109.0, 109.4, 132.9, 139.2, 145.3, 153.8, 158.5, 165.3, 168.8, 170.7, 172.1; IR (neat) ν~max~ 3274, 2924, 1782, 1732, 1651, 1518, 1205, 1066, 1016, 793 cm^-1^; HRMS (ESI): \[M+Na\]^+^ calculated for C~33~H~36~N~4~Na~3~O~21~S~2~: 957.1001, found: 957.1026. 10.7554/eLife.12509.045Appendix 1---figure 6.Synthesis of Azo-Leiker (AL, 13).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.045](10.7554/eLife.12509.045)

Reagents and conditions: (a) (1) Con. HCl, NaNO~2~, H~2~O, 0\~5 °C, 1.3 h; (2) **10**, NaOH, H~2~O, 0\~5 °C, 2 h, 88%; (b) TFA/DCM, 2.5 h; (c) **3**, TEA, DMSO, 24 h, 35% for two steps.10.7554/eLife.12509.046Appendix 1---figure 7.Compound 11.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.046](10.7554/eLife.12509.046)

Compound **11**: To a solution of compound **9** (131 mg, 0.89 mmol) in H~2~O (4 mL) was added Con. HCl (220 μL, 2.64 mmol) at 0\~5 °C, the reaction was stirred for 20 min. Subsequently, NaNO~2~ (86 mg, 1.24 mmol) dissolved in H~2~O (3 mL) was added. The resulting mixture was stirred at 0\~5 °C for 1 h. After that, the resulting mixture was added to the solution of compound **10** (207 mg, 0.89 mmol) in 0.6 M NaOH solution (4 mL) at 0\~5 °C dropwise. The reaction mixture was stirred at 0\~5 °C for 2 h. The mixture was neutralized with 0.25 M HCl, extracted with DCM (20 mL×3). The combined organic layers were washed with brine (10 mL). After dried over Na~2~SO~4~, the solution was concentrated *in vacuo* and purified by flash chromatography (silica gel, 30% EtOAc in petrol ether) to afford the desired compound **11** as a bright yellow waxy solid (298 mg, 88%): mp=133-135 °C; ^1^H NMR (400 MHz CDCl~3~): δ 1.45 (s, 9H), 2.57 (t, *J* = 2.4 Hz, 1H), 4.77 (m, 4H), 5.22 (br, 1H), 6.84 (dd, *J* = 8.8 Hz, 2.8 Hz, 1H), 7.01 (s, 1H), 7.08 (dd, *J* = 6.8 Hz, 2.0 Hz, 2H), 7.72 (d, *J* = 8.8 Hz, 1H), 7.86 (dd, *J* = 6.8 Hz, 2.0 Hz, 2H); ^13^C NMR (100 MHz CDCl~3~): δ 28.4, 41.4, 56.0, 76.0, 78.0, 80.2, 115.1, 115.67, 115.72, 118.0, 124.3, 139.6, 143.7, 147.7, 156.4, 159.3, 159.5; IR (neat) ν~max~ 3283, 2974, 1680, 1598, 1584, 1500, 1229, 1162, 1024, 837, 669 cm^-1^; HRMS (ESI): \[M+H\]^+^ calculated for C~21~H~24~N~3~O~4~: 382.1761, found: 382.1768.10.7554/eLife.12509.047Appendix 1---figure 8.Compound 12.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.047](10.7554/eLife.12509.047)

Compound **12**: To a solution of compound **11** (20.2 mg, 0.053 mmol) in DCM (2 mL) was added TFA (0.5 mL). The resulting mixture was stirred at room temperature for 2.5 h. The solvents were removed *in vacuo* to afford the crude product **12**, which was directly used for the next step.10.7554/eLife.12509.048Appendix 1---figure 9.Compound 13.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.048](10.7554/eLife.12509.048)

Compound **13**: To a solution of the crude product **3** (prepared from 23.2 mg of triacid) in DMSO (2 mL) was added compound **12** (prepared from 20.2 mg of compound **11**) dissolved in DMSO (0.5 mL). Triethylamine (50 μL, 0.36 mmol) was added to the solution subsequently. The reaction was stirred at room temperature for 24 h. DMSO was removed by using the genevac HT-4X evaporator and the product was isolated by HPLC (20-40% CH~3~CN in water over 18 min). CH~3~CN was removed *in vacuo* and water was removed by using Christ ALPHA 1-4 LD plus to yield a yellow solid (16.3 mg, 35% for two steps): mp=148-150 °C; ^1^H NMR (400 MHz DMSO): δ 1.62 (m, 7H), 2.17 (m, 2H), 2.65 (m, 6H), 2.86 (m, 2H), 3.61 (s, 1H), 3.94 (s, 2H), 4.76 (d, *J* = 4.8 Hz, 2H), 4.90 (s, 2H), 6.74 (d, *J* = 8.4 Hz, 1H), 6.85 (s, 1H), 7.15 (d, *J* = 8.8 Hz, 2H), 7.58 (d, *J* = 9.2 Hz, 1H), 7.85 (d, *J* = 8.8 Hz, 2.0 Hz, 2H), 8.35 (br, 1H), 10.17 (s, 1H); ^13^C NMR (100 MHz DMSO): δ 27.2, 27.6, 28.1, 30.9, 32.4, 35.4, 37.9, 55.8, 56.3, 78.6, 78.9, 114.5, 114.7, 115.4, 116.6, 124.1, 141.0, 142.1, 147.2, 159.0, 160.5, 165.4, 168.8, 172.2; IR (neat) ν~max~ 3323, 2947, 1737, 1618, 1594, 1217, 1036, 845, 672 cm^-1^; HRMS (ESI): \[M-Na\]^-^ calculated for C~34~H~33~N~5~NaO~17~S~2~: 870.1216, found: 870.1197.10.7554/eLife.12509.049Appendix 1---figure 10.Synthesis of biotinylated Azo-Leiker 1 (bAL 1, 17).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.049](10.7554/eLife.12509.049)

Reagents and conditions: (a) **14**, CuSO~4~.5H~2~O, sodium ascorbate, DCM/DMF/H~2~O, 24 h, 91%; (b) TFA/DCM, 2.5 h; (c) **3**, TEA, DMSO, 24 h, 37% for two steps.10.7554/eLife.12509.050Appendix 1---figure 11.Compound 15.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.050](10.7554/eLife.12509.050)

Compound **15**: To a solution of **11** (69.2 mg, 0.181 mmol) in DMF/DCM/H~2~O (2/2/2 mL) was added **14** (77 mg, 0.236 mmol), CuSO~4~.5H~2~O (2.3 mg, 0.009 mmol) and sodium ascorbate (5.4 mg, 0.027 mmol). The mixture was stirred at room temperature for 24 h. H~2~O (4 mL) was added, extracted with EtOAc (12 mL×3). The combined organic layers were washed with brine (5 mL). After dried over Na~2~SO~4~, the solution was concentrated *in vacuo* and purified by flash chromatography (silica gel, 6\~10% methanol in methylene chloride) to afford the desired compound **15** as a bright yellow waxy solid (117 mg, 91%): mp=120-122 °C; ^1^H NMR (400 MHz Methanol-d~4~): δ 1.44 (m, 2H), 1.48 (s, 9H), 1.64 (m, 4H), 2.13 (m, 2H), 2.21 (t, *J* = 7.6 Hz, 2H), 2.69 (d, *J* = 12.4 Hz, 1H), 2.90 (dd, *J* = 12.8 Hz, 5.2 Hz, 1H), 3.18 (m, 1H), 3.23 (t, *J* = 6.8 Hz, 2H), 4.28 (m, 1H), 4.47 (m, 3H), 4.78 (s, 2H), 5.26 (s, 2H), 6.76 (dd, *J* = 8.8 Hz, 2.8 Hz, 1H), 6.91 (d, *J* = 2.8 Hz, 1H), 7.14 (d, *J* = 9.2 Hz, 2H), 7.66 (d, *J* = 8.8 Hz, 1H), 7.87 (dd, *J* = 6.8 Hz, 2.0 Hz, 2H), 8.13 (s, 1H); ^13^C NMR (100 MHz Methanol-d~4~): δ 26.7, 28.9, 29.4, 29.8, 31.1, 36.7, 41.0, 41.2, 49.2, 57.0, 61.6, 62.6, 63.3, 80.3, 115.3, 115.8, 116.2, 118.1, 125.4, 125.6, 142.1, 144.2, 144.6, 149.0, 158.4, 161.6, 161.8, 166.0, 176.2; IR (neat) ν~max~ 3299, 2930, 1694, 1582, 1597, 1500, 1243, 1147, 838 cm^-1^; HRMS (ESI): \[M+H\]^+^ calculated for C~34~H~46~N~9~O~6~S: 708.3286, found: 708.3277.10.7554/eLife.12509.051Appendix 1---figure 12.Compound 16.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.051](10.7554/eLife.12509.051)

Compound **16**: To a solution of compound **15** (37.5 mg, 0.053 mmol) in DCM (2 mL) was added TFA (0.5 mL). The resulting mixture was stirred at room temperature for 2.5 h. The solvents were removed *in vacuo* to afford the crude product **16**, which was directly used for the next step.10.7554/eLife.12509.052Appendix 1---figure 13.Compound 17.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.052](10.7554/eLife.12509.052)

Compound **17**: To a solution of the crude product **3** (prepared from 23.2 mg of triacid) in DMSO (2 mL) was added compound **16** (prepared from 37.5 mg of compound **15**) dissolved in DMSO (0.5 mL). Triethylamine (50 μL, 0.36 mmol) was added to the solution subsequently. The reaction was stirred at room temperature for 24 h. DMSO was removed by using the genevac HT-4X evaporator and the product was isolated by HPLC (10-30% CH~3~CN in water over 18 min). CH~3~CN was removed *in vacuo* and water was removed by using Christ ALPHA 1-4 LD plus to yield a yellow solid (23.8 mg, 37% for two steps): mp=158-161 °C; ^1^H NMR (400 MHz DMSO): δ 1.30 (m, 2H), 1.57 (m, 11H), 1.96 (m, 2H), 2.21 (t, *J* = 7.6 Hz, 2H), 2.17 (m, 2H), 2.57 (d, *J* = 12.4 Hz, 1H), 2.65 (m, 4H), 2.74 (s, 2H), 2.81 (m, 3H), 3.00 (m, 3H), 3.95 (d, *J* = 6.4 Hz, 2H), 4.12 (m, 1H), 4.30 (m, 1H), 4.38 (t, *J* = 7.2 Hz, 2H), 4.76 (d, *J* = 5.6 Hz, 2H), 5.24 (s, 2H), 6.35 (s, 1H), 6.42 (s, 1H), 6.74 (dd, *J* = 8.8 Hz, 2.4 Hz, 1H), 6.85 (d, *J* = 2.4 Hz, 1H), 7.20 (d, *J* = 8.8 Hz, 2H), 7.58 (d, *J* = 8.8 Hz, 1H), 7.84 (d, *J* = 8.8 Hz, 2H), 7.90 (t, *J* = 5.6 Hz, 1H), 8.29 (s, 1H), 8.36 (t, *J* = 5.6 Hz, 1H), 10.16 (s, 1H); ^13^C NMR (100 MHz DMSO): δ 15.6, 25.3, 25.5, 27.2, 27.6, 28.0, 28.2, 30.0, 30.9, 32.4, 34.2, 35.2, 35.4, 35.7, 36.1, 37.9, 42.3, 47.3, 54.7, 55.4, 56.2, 56.3, 59.2, 61.0, 61.5, 114.5, 114.7, 115.2, 116.6, 124.2, 124.8, 140.9, 142.1, 142.3, 146.9, 158.5, 160.0, 160.5, 162.7, 165.3, 168.8, 172.18,172.25; IR (neat) ν~max~ 3321, 2939, 1717, 1685, 1601, 1524, 1257, 1174, 1142, 840 cm^-1^; HRMS (ESI): \[M-2Na\]^2-^ calculated for C~47~H~55~N~11~O~19~S~3~: 586.6424, found: 586.6413.10.7554/eLife.12509.053Appendix 1---figure 14.Synthesis of biotinylated Azo-Leiker 2 (bAL 2, 27).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.053](10.7554/eLife.12509.053)

Reagents and conditions: (a) **19**, DEAD, PPh~3~, THF, 0 °C, 1.5 h, 97 %; (b) FeSO~4~.7H~2~O, Fe, ethanol/H~2~O, 80°C, 18 h, 85 %; (c) (1) Con. HCl, NaNO~2~, H~2~O, 0\~5 °C, 1.3 h; (2) **10**, NaOH, H~2~O, 0\~5 °C, 2 h, 94 %; (d) TBAF, i-PrOH/DMF, 2 h, 95 %; (e) **24**, TEA, DMF, 2.5 h, 90 %; (f) TFA/DCM, 2.5 h; (g) **3**, TEA, DMSO, 24 h, 44% for two steps.10.7554/eLife.12509.054Appendix 1---figure 15.Compound 20.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.054](10.7554/eLife.12509.054)

Compound **20**: 4-nitrophenol **18** (211 mg, 1.52 mmol) was dissolved in anhydrous THF (37 mL), compound **19** (519 mg, 1.75 mmol), PPh~3~ (344 mg, 1.97 mmol), DEAD (518 mg, 1.97 mmol) were added at 0 °C subsequently. The reaction mixture was stirred at 0 °C for 1.5 h. The mixture was quenched with sat. NH~4~Cl solution (10 mL), extracted with CH~2~Cl~2~ (15 mL×3). The combined organic layers were washed with brine (10 mL). After dried over Na~2~SO~4~, the solution was concentrated *in vacuo* and purified by flash chromatography (silica gel, 25% EtOAc in petrol ether) to afford the desired compound **20** as a white solid (615 mg, 97%): mp=128-130 °C; ^1^H NMR (400 MHz CDCl~3~): δ 2.04 (m, 2H), 3.41 (m, 2H), 4.09 (t, *J* = 6.0 Hz, 2H), 4.21 (t, *J* = 6.4 Hz, 1H), 4.44 (d, *J* = 6.8 Hz, 2H), 4.94 (br, 1H), 6.93 (m, 2H), 7.31 (m, 2H), 7.40 (m, 2H), 7.58 (m, 2H), 7.77 (m, 2H), 8.19 (m, 2H); ^13^C NMR (100 MHz CDCl~3~): δ 29.3, 38.1, 47.2, 66.3, 66.5, 114.4, 120.0, 124.9, 125.9, 127.0, 127.7, 141.3, 141.6, 143.8, 156.4, 163.7; IR (neat) ν~max~ 3325, 2951, 1702, 1592, 1509, 1448, 1335, 1256, 1109, 844, 741 cm^-1^; HRMS (ESI): \[M+Na\]^+^ calculated for C~24~H~22~N~2~NaO~5~: 441.1421, found: 441.1424.10.7554/eLife.12509.055Appendix 1---figure 16.Compound 21.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.055](10.7554/eLife.12509.055)

Compound **21**: To a solution of compound **20** (598 mg, 1.43 mmol) in ethanol/H~2~O (15 mL/4.5 mL) was added FeSO~4~.7H~2~O (80 mg, 0.286 mmol) and iron dust (705 mg, 12. 6 mmol). The reaction mixture was stirred at 80 °C for 18 h. The reaction mixture was filtered over a short pad of silica gel with EtOAc as the eluant, the filtrate was removed by rotary evaporation. The residue was dissolved in EtOAc (50 mL), washed with H~2~O (10 mL). After dried over Na~2~SO~4~, the solution was concentrated *in vacuo* and purified by flash chromatography (silica gel, 30% EtOAc in petrol ether) to afford the desired compound **21** as a waxy solid (471 mg, 85%): ^1^H NMR (400 MHz CDCl~3~): δ 1.96 (m, 2H), 3.40 (m, 4H), 3.96 (t, *J* = 6.0 Hz, 2H), 4.22 (t, *J* = 7.2 Hz, 1H), 4.40 (d, *J* = 6.8 Hz, 2H), 5.14 (br, 1H), 6.64 (m, 2H), 6.70 (m, 2H), 7.31 (m, 2H), 7.40 (m, 2H), 7.60 (m, 2H), 7.76 (m, 2H); ^13^C NMR (100 MHz CDCl~3~): δ 29.3, 38.8, 47.3, 66.5, 66.6, 115.6, 116.4, 119.9, 125.0, 127.0, 127.6, 140.2, 141.3, 144.0, 151.8, 156.4; IR (neat) ν~max~ 3348, 2950, 1704, 1510, 1449, 1233, 1044, 825, 741 cm^-1^; HRMS (ESI): \[M+H\]^+^ calculated for C~24~H~25~N~2~O~3~: 389.1860, found: 389.1866.10.7554/eLife.12509.056Appendix 1---figure 17.Compound 22.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.056](10.7554/eLife.12509.056)

Compound **22**: To a solution of compound **21** (345 mg, 0.89 mmol) in H~2~O (4 mL) was added Con. HCl (220 μL, 2.64 mmol) at 0\~5 °C, the reaction was stirred for 20 min. Subsequently, NaNO~2~ (86 mg, 1.24 mmol) dissolved in H~2~O (3 mL) was added. the resulting mixture was stirred at 0\~5 °C for 1 h. After that, the resulting mixture was added to the solution of compound **10** (207 mg, 0.89 mmol) in 0.6 M NaOH solution (4 mL) at 0\~5 °C dropwise. The reaction mixture was stirred at 0\~5 °C for 2 h. The mixture was neutralized with 0.25 M HCl, extracted with DCM (20 mL×3). The combined organic layers were washed with brine (10 mL). After dried over Na~2~SO~4~, the solution was concentrated *in vacuo* and purified by flash chromatography (silica gel, 30% EtOAc in petrol ether) to afford the desired compound **22** as a bright yellow solid (520 mg, 94%): mp=79-81 °C; ^1^H NMR (400 MHz CDCl~3~): δ 1.44 (s, 9H), 2.05 (m, 2H), 3.44 (m, 2H), 4.10 (m, 2H), 4.22 (t, *J* = 6.8 Hz, 1H), 4.44 (d, *J* = 6.8 Hz, 2H), 4.76 (d, *J* = 6.4 Hz, 2H), 5.03 (br, 1H), 5.17 (br, 1H), 6.83 (dd, *J* = 8.8 Hz, 2.8 Hz, 1H), 6.70 (m, 3H), 7.31 (m, 2H), 7.40 (m, 2H), 7.60 (m, 2H), 7.72 (d, *J* = 8.8 Hz, 1H), 7.77 (d, *J* = 7.2 Hz, 2H), 7.84 (d, *J* = 8.8 Hz, 2H); ^13^C NMR (100 MHz CDCl~3~): δ 28.4, 29.3, 38.4, 41.3, 47.2, 65.9, 66.6, 79.9, 114.6, 115.6, 115.7, 117.8, 119.9, 124.4, 124.9, 127.0, 127.7, 139.6, 141.3, 143.8, 147.3, 156.3, 156.6, 159.3, 160.6; IR (neat) ν~max~ 3298, 2928, 1686, 1597, 1501, 1467, 1240, 1144, 837, 741 cm^-1^; HRMS (ESI): \[M+H\]^+^ calculated for C~36~H~39~N~4~O~6~: 623.2864, found: 623.2855.10.7554/eLife.12509.057Appendix 1---figure 18.Compound 23.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.057](10.7554/eLife.12509.057)

Compound **23**: To a solution of compound **22** (494 mg, 0.79 mmol) in *i*PrOH/DMF (1.5 mL/15 mL) was added TBAF (0.04 M in DMF, 30 mL, 1.2 mmol) dropwise. The reaction was stirred at room temperature for 2 h. The mixture was quenched with sat. NH~4~Cl solution (15 mL), extracted with EtOAc (40 mL×3). The combined organic layers were washed with brine (20 mL). After dried over Na~2~SO~4~, the solution was concentrated *in vacuo* and purified by flash chromatography (silica gel, 6\~10% methanol in methylene chloride) to afford the desired compound **23** as a bright yellow solid (317 mg, 95%): mp=182-184 °C; ^1^H NMR (400 MHz DMSO): δ 1.41 (s, 9H), 1.93 (t, *J* = 6.4 Hz, 2H), 2.85 (t, *J* = 6.4 Hz, 2H), 3.33 (br, 2H), 4.14 (t, *J* = 6.4 Hz, 2H), 4.65 (d, *J* = 6.0 Hz, 2H), 6.73 (dd, *J* = 8.8 Hz, 2.8 Hz, 1H), 6.85 (d, *J* = 2.4 Hz, 1H), 7.09 (dd, *J* = 6.8 Hz, 2.0 Hz, 2H), 7.37 (t, *J* = 6.0 Hz, 1H), 7.57 (d, *J* = 8.8 Hz, 1H), 7.83 (dd, *J* = 6.8 Hz, 2.0 Hz, 2H); ^13^C NMR (100 MHz DMSO): δ 28.3, 29.6, 37.2, 65.5, 77.8, 114.0, 114.6, 114.9, 116.4, 124.1, 141.3, 141.8, 146.7, 155.8, 160.4, 160.7; IR (neat) ν~max~ 3468, 2975, 1682, 1598, 1583, 1502, 1248, 1165, 836 cm^-1^; HRMS (ESI): \[M+H\]^+^ calculated for C~21~H~29~N~4~O~4~: 401.2183, found: 401.2187.10.7554/eLife.12509.058Appendix 1---figure 19.Compound 25.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.058](10.7554/eLife.12509.058)

Compound **25**: To a solution of biotin pentafluorophenyl ester **24** (46 mg, 0.11 mmol) in anhydrous DMF (1 mL) was added compound **23** (37 mg, 0.093 mmol) in anhydrous DMF (1.5 mL) dropwise. Triethylamine (26 μL, 0.187 mmol) was added to the solution subsequently. The reaction was stirred at room temperature for 2.5 h. The solvent was removed in vacuo and the crude product was purified by flash chromatography (silica gel, 3\~9% methanol in methylene chloride) to afford the desired product **25** as a bright yellow solid (52 mg, 90%): mp=124-126 °C; ^1^H NMR (400 MHz DMSO): δ 1.30 (m, 2H), 1.41 (s, 9H), 1.54 (m, 4H), 1.88 (t, *J* = 6.4 Hz, 2H), 2.08 (t, *J* = 7.6 Hz, 2H), 2.59 (d, *J* = 12.4 Hz, 1H), 2.79 (dd, *J* = 12.4 Hz, 4.8 Hz, 1H), 3.07 (m, 1H), 3.23 (m, 2H), 4.09 (m,3H), 4.28 (m, 1H), 4.66 (d, *J* = 5.6 Hz, 2H), 6.37 (s, 1H), 6.44 (s, 1H), 6.74 (dd, *J* = 8.8 Hz, 2.4 Hz, 1H), 6.86 (d, *J* = 2.0 Hz, 1H), 7.07 (d, *J* = 8.8 Hz, 2H), 7.34 (t, *J* = 6.0 Hz, 1H), 7.58 (d, *J* = 8.8 Hz, 1H), 7.83 (d, *J* = 8.8 Hz, 2H), 7.90 (t, *J* = 5.6 Hz, 1H), 10.13 (s, 1H); ^13^C NMR (100 MHz DMSO): δ 25.3, 28.0, 28.2, 28.3, 28.9, 35.2, 35.3, 39.9, 55.4, 59.2, 61.0, 65.7, 77.8, 114.0, 114.5, 114.9, 116.5, 124.2, 141.3, 141.9, 146.7, 155.8, 160.4, 160.5, 162.7, 172.1; IR (neat) ν~max~ 3287, 2930, 1692, 1596, 1581, 1501, 1243, 1163, 838 cm^-1^; HRMS (ESI): \[M+H\]^+^ calculated for C~31~H~43~N~6~O~6~S: 627.2959, found: 627.2951.10.7554/eLife.12509.059Appendix 1---figure 20.Compound 26.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.059](10.7554/eLife.12509.059)

Compound **26**: To a solution of compound **25** (33.3 mg, 0.053 mmol) in DCM (2 mL) was added TFA (0.5 mL). The resulting mixture was stirred at room temperature for 2.5 h. The solvents were removed in vacuo to afford the crude product **26**, which was directly used for the next step.10.7554/eLife.12509.060Appendix 1---figure 21.Compound 27.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.060](10.7554/eLife.12509.060)

Compound **27**: To a solution of the crude product **3** (prepared from 23.2 mg of triacid) in DMSO (2 mL) was added compound **26** (prepared from 33.3 mg of compound **25**) dissolved in DMSO (0.5 mL). Triethylamine (50 μL, 0.36 mmol) was added to the solution subsequently. The reaction was stirred at room temperature for 24 h. DMSO was removed by using the genevac HT-4X evaporator and the product was isolated by HPLC (20-40% CH~3~CN in water over 18 min). CH~3~CN was removed *in vacuo* and water was removed by using Christ ALPHA 1-4 LD plus to yield a yellow solid (26.5 mg, 44% for two steps): mp=152-154°C; ^1^H NMR (400 MHz DMSO): δ 1.31 (m, 2H), 1.57 (m, 11H), 1.88 (m, 2H), 2.07 (t, *J* = 7.2 Hz, 2H), 2.18 (m, 2H), 2.56 (d, *J* = 12.8 Hz, 1H), 2.65 (m, 4H), 2.76 (s, 2H), 2.83 (m, 3H), 3.00 (m, 1H), 3.20 (m, 2H), 3.95 (d, *J* = 7.2 Hz, 2H), 4.09 (m, 3H), 4.28 (m, 1H), 4.76 (d, *J* = 5.6 Hz, 2H), 6.34 (s, 1H), 6.41 (s, 1H), 6.74 (dd, *J* = 8.8 Hz, 2.4 Hz, 1H), 6.85 (d, *J* = 2.4 Hz, 1H), 7.08 (d, *J* = 8.8 Hz, 2H), 7.58 (d, *J* = 8.8 Hz, 1H), 7.83 (d, *J* = 8.8 Hz, 2H), 7.89 (t, *J* = 5.6 Hz, 1H), 8.36 (t, *J* = 5.6 Hz, 1H), 10.14 (s, 1H); ^13^C NMR (100 MHz DMSO): δ 15.6, 25.3, 25.5, 27.2, 27.6, 28.0, 28.2, 28.9, 30.9, 32.4, 34.2, 35.2, 35.3, 36.0, 37.9, 42.3, 54.6, 55.4, 56.3, 59.2, 61.0, 65.7, 114.4, 114.7, 114.9, 124.2, 140.8, 142.1, 146.7, 158.5, 160.4, 160.6, 162.7, 165.3, 168.8, 172.1, 172.2; IR (neat) ν~max~ 3328, 2937, 1737, 1714, 1650, 1597, 1234, 1040, 631 cm^-1^; HRMS (ESI): \[M-2Na\]^2-^ calculated for C~44~H~52~N~8~O~19~S~3~: 546.1261, found: 546.1265.10.7554/eLife.12509.061Appendix 1---figure 22.Synthesis of d~6~-biotinylated Azo-Leiker 2 (bAL 2, 31).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.061](10.7554/eLife.12509.061)

Reagents and conditions: (a) sat. KOH, 105 °C, 2 d, 84%; (b) **2**, EDCI, DMSO, 24 h; (c) **26**, TEA, DMSO, 24 h, 31% for two steps.10.7554/eLife.12509.062Appendix 1---figure 23.Compound 29.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.062](10.7554/eLife.12509.062)

Compound **29**: A solution of compound **28** (102 mg, 0.42 mmol, Note: compound **28** was synthesized with acrylonitrile-d~3~ (purchased from CDN) as the starting material. The procedure was the same as compound **1**. Unfortunately it lost some deuterium during the procedure) in sat. KOH aqueous (2 mL) was stirred at 105 °C for 2 d. The mixture was acidified with con. HCl, extracted with DCM (100 mL×3). The combined organic layers were washed with brine (5 mL). After dried over Na~2~SO~4~, the solution was concentrated *in vacuo* to give the desired product **29** as a white solid (85 mg, 84%): mp=107-109°C; ^1^H NMR (400 MHz DMSO): δ 1.28 (s, 1H), 2.16 (s, 6H), 12.02 (s, 3H); ^13^C NMR (100 MHz DMSO): δ 30.7, 35.0, 174.6; IR (neat) ν~max~ 2925, 1696, 1413, 1283, 1217, 911 cm^-1^; HRMS (ESI): \[M+K\]^+^ calculated for C~10~H~10~D~6~KO~6~: 277.0955, found: 277.0956.10.7554/eLife.12509.063Appendix 1---figure 24.Compound 30.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.063](10.7554/eLife.12509.063)

Compound **30**: To a solution of d~6~-triacid **29** (23.8 mg, 0.1 mmol) in anhydrous DMSO (5 mL) was added **2** (71.6 mg, 0.33 mmol) and EDCI (67.1 mg, 0.35 mmol). The reaction was stirred at room temperature for 24 h. After that, 40 mL of anhydrous THF was added, and the solution became muddy. The solvents were poured out after standing overnight to give the crude product **30**, which was directly used for the next step.10.7554/eLife.12509.064Appendix 1---figure 25.Compound 31.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.064](10.7554/eLife.12509.064)

Compound **31**: To a solution of the crude product **30** (prepared from 23.8 mg of d~6~-triacid **29**) in DMSO (2 mL) was added compound **26** (prepared from 33.3 mg of compound **25**) dissolved in DMSO (0.5 mL). Triethylamine (50 μL, 0.36 mmol) was added to the solution subsequently. The reaction was stirred at room temperature for 24 h. DMSO was removed by using the genevac HT-4X evaporator and the product was isolated by HPLC (20-40% CH~3~CN in water over 18 min). CH~3~CN was removed *in vacuo* and water was removed by using Christ ALPHA 1-4 LD plus to yield a yellow solid (18.8 mg, 31% for two steps): mp=154-156°C; ^1^H NMR (400 MHz DMSO): δ 1.30 (m, 2H), 1.50 (m, 5H), 1.88 (m, 2H), 2.07 (t, *J* = 7.2 Hz, 2H), 2.16 (m, 2H), 2.56 (d, *J* = 12.4 Hz, 1H), 2.63 (m, 4H), 2.69 (s, 2H), 2.81 (m, 3H), 3.05 (m, 1H), 3.21 (m, 2H), 3.95 (d, *J* = 6.8 Hz, 2H), 4.09 (m, 3H), 4.28 (m, 1H), 4.76 (d, *J* = 5.6 Hz, 2H), 6.34 (s, 1H), 6.41 (s, 1H), 6.74 (dd, *J* = 8.8 Hz, 2.4 Hz, 1H), 6.85 (d, *J* = 2.4 Hz, 1H), 7.08 (d, *J* = 9.2 Hz, 2H), 7.58 (d, *J* = 8.8 Hz, 1H), 7.83 (d, *J* = 8.8 Hz, 2H), 7.90 (t, *J* = 5.6 Hz, 1H), 8.36 (t, *J* = 5.6 Hz, 1H), 10.16 (s, 1H); ^13^C NMR (100 MHz DMSO): δ 25.3, 27.4, 28.1, 28.2, 28.9, 30.9, 34.9, 35.2, 35.4, 37.9, 54.9, 55.4, 56.2, 56.3, 59.2, 61.1, 65.7, 114.5, 114.7, 114.9, 116.6, 124.2, 140.8, 142.1, 146.7, 160.4, 160.6, 162.7, 165.4, 168.8, 172.1, 172.3; IR (neat) ν~max~ 3325, 2932, 1738, 1712, 1647, 1587, 1236, 1042, 636 cm^-1^; HRMS (ESI): \[M-2Na\]^2-^ calculated for C~44~H~46~D~6~N~8~O~19~S~3~: 549.1449, found: 549.1449.
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Thank you for submitting your work entitled \"Leiker, A Cross-Linker for Mapping Protein-Protein Interaction Networks and Comparing Protein Conformational States\" for consideration by *eLife*. Your article has been reviewed by four peer reviewers, one of whom was a guest editor and the evaluation has been overseen by John Kuriyan as the Senior Editor. One of the four reviewers has agreed to reveal his identity: Jeff Ranish.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The authors describe the use of tri-functional crosslinking reagents for CX-MS studies with one of the reagent\'s functionalities being the biotin affinity tag and the other two being amine-reactive moieties. The basic idea here is to enrich crosslinked and crosslink-modified peptides from mixtures of peptides generated from protein assemblies. While this concept and its demonstration is not new, the value of the present study lies in its experimental tests and assessment of the utility of such trifunctional crosslinking reagents for enriching information-filled crosslink-modified peptides from a large background of unmodified peptides. In this respect, there are components of the manuscript that have considerable potential value (especially the section entitled \"Leiker enabled robust enrichment of cross-linked peptides\"). At the same time other components of the study are either not well enough described to have real value or the conclusions from these components are insufficiently justified (especially the section entitled \"Application of Leiker to lysates\"). Therefore, publication of this work can only be supported provided that the authors adequately address the detailed points listed below.

Detailed Comments:

1\) With respect to the prior work the authors state \"....as proposed previously (Trester-Zedlitz et al., 2003).\" The paper referred to is a JACS article with a full description of a large range of modular trifunctional crosslinks of the kind repeated in the present study, so this earlier work cannot be considered merely a proposal, but rather a careful description and demonstration of the chemical synthesis of these reagents, as well as their application. The authors should more accurately represent their work in the light of the prior work, and certainly the re-naming of the strategy associated with the use of trifunctional crosslinking reagents as \"Leiker\" is inappropriate.

2\) Also with respect to prior work, the authors apply trifunctional reagents to a study of crosslinking within exosome complexes isolated from *S. cerevisiae*. Exosome complexes have been studied previously in the Shi et al. 2015 paper that was referred to in the manuscript. In order to allow the reader to better assess the relative merits of the present approach versus those used formerly, the authors should compare and contrast their results with this prior work, which was performed with standard bifunctional crosslinking reagents. Points of interest here include a comparison of the number of inter-subunit crosslinks, the relative amounts of sample used, and any differences in the information gained in these two cases. This comparison should prove of greater value to the reader than the comparisons that are made in the manuscript, which are comparisons between the results provided by the author and early two-hybrid experiments as well as to just a single crosslink data point in the Shi et al. 2015 paper.

3\) The authors state that there is a HCD reporter ion at *m/z* 122.0606 generated from their reagent ([Figure 2](#fig2){ref-type="fig"}). It would be helpful for the authors to state what use, if any, they make of this reporter ion and if it is always observed.

4\) It is important to specify more precisely what is meant by \"...a crude immunoprecipitate of TAP-tagged Rrp46\" in terms of purity? What do the products of this affinity isolation look like on an SDS-PAGE gel or by mass spectrometric analysis?

5\) The experiment shown in [Figure 3](#fig3){ref-type="fig"} appears to be a convincing demonstration of the potential utility of the described technique for increasing the information content of crosslinking studies, especially in complex mixtures of proteins. I believe that this is the most convincing and valuable data that is provided by the authors. However, because the described technique involves additional steps to those carried out in more conventional crosslinking experiments, it is important to evaluate the cost in sensitivity (if any) that this gain in information content is accomplished. This is especially important for real world samples of affinity isolated complexes, where the amount of sample is often limiting. Thus, this study will be more valuable if the authors provide information on the data falloff as a function of decreasing the quantity of the ten protein mixture. Also, the individual amounts of each protein should be provided, not just the total amounts of all ten proteins and the names of the proteins should be supplied in the paper proper rather than just in the Supplementary data. Finally, because structures for most of these proteins are available, the α-carbon to α-carbon distance distribution for all the inter-links should be provided and assessed as a measure of x-link veracity.

6\) The authors utilize identification of artefactual inter-protein crosslinks to assess the specificity of the trifunctional reagents versus BS~3~. It is also of interest to ascertain whether these larger reagents are more sterically hindered in accessing reactive amines. This requires comparing data obtained on standards such as the 10 proteins using e.g. BS~3~ versus the tri-functional reagents. Since this data already exists, it appears straightforward to make this comparison. Indeed from [Figure 3A](#fig3){ref-type="fig"} it appears that their technique yields approximately 50% less of crosslinks comparing to DSS. This point needs to be properly addressed.

7\) In the experimental data shown in [Figure 3](#fig3){ref-type="fig"}, the authors found that even in a 100-fold excess of *E. coli* lysate over the protein standards approx. 97% of the identified peptides were crosslinked peptides -- i.e., they observed something like a 100-fold enhancement of crosslinked peptides under these conditions. However in the *E. coli* lysate, the authors only observed a 4-fold increase in the crosslinks treated with tri-functional reagents compared to that treated with BS~3~ ([Figure 3B](#fig3){ref-type="fig"}). The authors need to explain this observation? (This question is related to 16 below).

8\) Crosslinks do not necessarily define direct protein-protein interactions due to their relatively long distance thresholds (here \>25 angstroms), although in many cases they do. Thus, it is more accurate to interpret the data as defining \"protein spatial connectivity\" or \"spatial restraints\" instead.

9\) The crosslink data appears sparse by current day standards. Discuss why you think this is the case. How much material was used in the ribosome crosslinking study?

10\) Concerning the application of the described method to an analysis of crosslinking of proteins within lysates, it is of interest to provide data on the relative information provided in the three independent experiments to give the reader a feel for the amount of data that can be expected from a single experiment as well as their reproducibility.

The authors should further discuss \'half of the BS~3~ identified cross-links from *E. coli* were recapitulated in this study\' (subsection "Application of Leiker to lysates", second paragraph)? If after enrichment 50% of previously identified crosslinkers are not identified, does it mean that the generated crosslinks themselves vary dramatically or the enrichment is simply not exhaustive enough? For that reason the authors should state how much overlap there is between the crosslinks of the biological replicates.

11\) Crosslink data analysis. For their large database searches, did the authors try to filter and estimate the FDRs separately for intersubunit and intersubunit crosslinks? (Trnka et al. MCP, 2014). If not, the authors could, for example, search their 70S dataset using two different databases: either a small database (containing only the ribosome proteins) or a large database (with hundreds of proteins) and compare the differences (mapped to the available atomic structure). In any event, the authors should to upload their inter-peptide spectra to allow the interested reader to assess the crosslinked peptides data quality (scores do not always allow this because the good score may be dominated by one of the two peptides within the pair).

12\) It is in the first paragraph of the subsection "Application of Leiker to lysates" that most of the inter-molecule cross-links suggest novel protein-protein interactions. Exactly how was this assessed?

13\) I find [Figure 5](#fig5){ref-type="fig"} to be largely uninformative. The authors must find a more informative way of presenting this or part of this data. It seems likely that the observed inter-molecule interactions are strongly skewed by the relative abundance of the proteins in the lysates. An assessment of this data in terms of the abundance of the proteins could provide valuable information on the rules underlying the observation of interaction in such complex mixtures. Depending on the results, it might also be valuable to discuss other possible reasons for why these particular interactions are observed.

14\) I could not make sense of the sentence "Applying the same procedure to the previously identified BS^3^ cross-links (Yang, et al., 2012), we obtained only three ribosomal proteins in the most highly connected modules ([Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"})", nor could I find [Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}. Indeed I was unable to make proper sense of the second half of the subsection "Application of Leiker to lysates". I also did not find the recitation of numbers in this section particularly useful or meaningful. The points that I think are ostensibly being made in this section need to be made much more clearly.

15\) The data from the whole-proteome CX-MS analysis of *C. elegans* appears sparse (with just a few hundred crosslinks identified). What is the reason for this? (See also Q 16). Is this because of limitations of the software? If this is the case, perhaps it would help to use a smaller database containing only the top 1,000 most abundant proteins (since identifying crosslinks from the less abundant proteins would appear unlikely anyway)?

16\) While I agree with the authors that better sample preparation and more sensitive instrumentation could help to reduce the crosslinking problem caused by the huge dynamic range of proteins within proteomes, I am not convinced that these are actually the most important barriers to overcome for proteome-wide crosslinking profiling for at least two reasons:

A\) Within cells, the majority of protein complexes are not abundant. Thus, using the current crosslinking protocol without prior affinity enrichment of the complexes of interest, the majority of such complexes will not be efficiently crosslinked because of the low efficiency for crosslinking low abundance complexes.

B\) And even if one could crosslink the proteome efficiently using more efficient reagents, glueing the cellular components together would likely lead to daunting challenges in inducing the needed proteolysis.

17\) [Figure 8](#fig8){ref-type="fig"}. Reliable quantitative CX-MS analysis can be very challenging due to the low abundance of crosslink ions. What is the reproducibility of the quantitative data? Error bars from the repeat experiments would help here. Indeed without stronger quantitative data, it is not justified to entitle the paper: \"Leiker, A Cross-Linker for Mapping Protein-Protein Interaction Networks and comparative cross-link analysis\" at least with respect to the \"aspect of comparative cross-link analysis\".

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

Thank you for resubmitting your work entitled \"Leiker, A Cross-Linker for Mapping Protein-Protein Interaction Networks and Comparing Protein Conformational States\" for further consideration at *eLife*. Your revised article has been favorably evaluated by John Kuriyan (Senior editor) and a Reviewing editor. The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below:

Concerning the title, it is not acceptable to us that you use the acronym LEIKER (Lysine-targeted enrichable cross-linker) in the title or Abstract of the paper. We note that you have now acceded to the request to properly attribute the 2003 JACS article, which previously described trifunctional reagents with the same basic properties as the present trifunctional reagent. We note that you still wish to name your process by an acronym (Lysine-targeted enrichable cross-linker (Leiker) even though this was thought to be inappropriate by the reviewers. The reviewers\' objection to the acronym was that in giving a new name to a previously published strategy, you might effectively take possession of an idea that did not originate with the present work. Therefore, in order for this work to be published in *eLife*, you may use the acronym LEIKER in the main body of the paper, but not in the title or the Abstract.

10.7554/eLife.12509.104

Author response

*Detailed Comments: 1) With respect to the prior work the authors state \"....as proposed previously (Trester-Zedlitz et al., 2003).\" The paper referred to is a JACS article with a full description of a large range of modular trifunctional crosslinks of the kind repeated in the present study, so this earlier work cannot be considered merely a proposal, but rather a careful description and demonstration of the chemical synthesis of these reagents, as well as their application. The authors should more accurately represent their work in the light of the prior work, and certainly the re-naming of the strategy associated with the use of trifunctional crosslinking reagents as \"Leiker\" is inappropriate.* A) Leiker is not a collective term of all trifunctional cross-linkers; it is one type of design that we selected out of many and it truly meets the expectation for trifunctional cross-linkers. In the winner design, the azobenzene-based cleavage site has never been applied to the synthesis of cross-linkers previously. What distinguishes this study from other similar ones is the extensive, meticulous testing of multiple trifunctional cross-linkers and finding the best one for CXMS users. It is a heavy burden to test different cross-linkers. For example, we spent two years on the two-piece design before giving it up. No users would have the patience to test multiple cross-linkers in depth when they really want is one that works.

B\) We have changed "...as proposed previously" to "...as pioneered previously".

2\) Also with respect to prior work, the authors apply trifunctional reagents to a study of crosslinking within exosome complexes isolated from S. cerevisiae. Exosome complexes have been studied previously in the Shi et al.

*2015 paper that was referred to in the manuscript. In order to allow the reader to better assess the relative merits of the present approach versus those used formerly, the authors should compare and contrast their results with this prior work, which was performed with standard bifunctional crosslinking reagents. Points of interest here include a comparison of the number of inter-subunit crosslinks, the relative amounts of sample used, and any differences in the information gained in these two cases. This comparison should prove of greater value to the reader than the comparisons that are made in the manuscript, which are comparisons between the results provided by the author and early two-hybrid experiments as well as to just a single crosslink data point in the Shi et al. 2015 paper.* We made a comparison of the two studies (Author response [table 1](#tbl1){ref-type="table"}). Shi et al. used 15 μg of highly purified exosome complexes (44 proteins identified), and we used 40 μg of crude exosome complexes (740 proteins identified). The sample analyzed by Shi et al. included both cytosolic and nuclear exosomes and ours had only cytosolic exosome, with the overlap being the exosome core complex. Thus, the cross-links involving the ten exosome core subunits were compared. At FDR \< 0.05, 59 out of 88 cross-links reported by Shi et al. were detected in this study ([Author response image 1](#fig62){ref-type="fig"}).10.7554/eLife.12509.093Author response table 1.Comparison of this study and Shi et al. study of the exosome complex.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.093](10.7554/eLife.12509.093)LeikerDSS (Shi et al.)filtering criteriaFDR \< 0.05FDR \< 0.05,E-value \< 0.00001, spectral count ≥ 3FDR \< 0.05,manual inspection\#total cross-links625195211\#inter-subunit cross-links3624379\#intra-subunit cross-links263152132amount of sample40 μg15 μg\#proteins in the sample740 (FDR 0.1%)44 (FDR \~1%)sample puritypoorgoodtype of exosomecytosolic exosome(in the Rrp6 deletion background)cytosolic exosomeand nuclear exosomedatabase for pLink search740 proteins17 proteins10.7554/eLife.12509.094Author response image 1.Overlap of inter-links between subunits of the exosome core complex.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.094](10.7554/eLife.12509.094)

*3) The authors state that there is a HCD reporter ion at m/z 122.0606 generated from their reagent ([Figure 2](#fig2){ref-type="fig"}). It would be helpful for the authors to state what use, if any, they make of this reporter ion and if it is always observed.*

The *m/z* 122.0606 reporter ion is always observed with high intensity in the MS2 spectra of peptides modified by Leiker (after their release from the streptavidin beads by cleavage of azobenzene). It is either not observed or observed with low intensity in the MS2 spectra of regular peptides (not modified by Leiker) due to contamination of co-eluting Leiker-modified peptides in the 2-Da isolation window of precursor ions for MS2. The Intensity distribution is shown in [Author response image 2](#fig63){ref-type="fig"}. The *m/z* 122.0606 reporter ion serves to verify the identification of Leiker-cross-linked peptides. It can also be used to filter spectra, however, we did not use it this way because after enrichment using streptavidin beads, the resulting spectra are predominantly of Leiker-modified peptides. We added a sentence to the manuscript to state its use.10.7554/eLife.12509.095Author response image 2.Intensity distributions of the reporter ion of *m/z* 122.0606 for different types of peptides.In each category, the FDR of peptide-spectrum match (PSM) is 5%. The data came from the ten standard proteins.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.095](10.7554/eLife.12509.095)

*4) It is important to specify more precisely what is meant by \"...a crude immunoprecipitate of TAP-tagged Rrp46\" in terms of purity? What do the products of this affinity isolation look like on an SDS-PAGE gel or by mass spectrometric analysis?*

For comparison, a SDS-PAGE gel of the crude immunoprecipitate of

TAP-tagged Rrp46 used in this study (left) is shown next to the SDS-PAGE of the purified exosome sample by Shi et al. (right) ([Author response image 3](#fig64){ref-type="fig"}). The purity of the exosome sample used by Shi et al. is far better. In fact, a total of 740 (protein FDR 0.1%) and 44 (protein FDR \~1%) proteins were identified, respectively, in our sample and in the sample of Shi et al.. This is described in the Methods section, under the subsection "Identification of cross-linked peptides with pLink".10.7554/eLife.12509.096Author response image 3.Silver-stained SDS-PAGE of the crude immunoprecipitate of TAP-tagged Rrp46 (left) and the SDS-PAGE of the purified exosome sample of Shi et al. (right).**DOI:** [http://dx.doi.org/10.7554/eLife.12509.096](10.7554/eLife.12509.096)

*5) The experiment shown in [Figure 3](#fig3){ref-type="fig"} appears to be a convincing demonstration of the potential utility of the described technique for increasing the information content of crosslinking studies, especially in complex mixtures of proteins. I believe that this is the most convincing and valuable data that is provided by the authors. However, because the described technique involves additional steps to those carried out in more conventional crosslinking experiments, it is important to evaluate the cost in sensitivity (if any) that this gain in information content is accomplished. This is especially important for real world samples of affinity isolated complexes, where the amount of sample is often limiting. Thus, this study will be more valuable if the authors provide information on the data falloff as a function of decreasing the quantity of the ten protein mixture. Also, the individual amounts of each protein should be provided, not just the total amounts of all ten proteins and the names of the proteins should be supplied in the paper proper rather than just in the Supplementary data. Finally, because structures for most of these proteins are available, the α-carbon to α-carbon distance distribution for all the inter-links should be provided and assessed as a measure of x-link veracity.*

A\) We thank the reviewers for the suggestion of testing the sensitivity of our method---such information will be very valuable for users. From ourexperience, BS~3~ or DSS is a better choice for low-complexity samples of limiting amounts; Leiker is superior for high-complexity samples of adequate amounts; nothing works for minute amounts of high-complexity samples. We used the immunoprecipitated exosome sample, instead of the ten-protein mixture, for the sensitivity test for two reasons: 1. The ten-protein mix is too simple to mimic real-world samples of immunoprecipitated proteins; 2. as shown in [Figure 3A (1:0](#fig3){ref-type="fig"} dilution), Leiker has little advantage on this simple protein mixture over BS~3~. The input amount of the exosome sample was varied from 40 μg to 3 μg. We found that the number of inter-link identifications stayed about the same as the input decreased from 40 to 20 μg. A sharp decrease was observed when the input was reduced from 20 to 10 μg or lower. This information is added to the revised manuscript as [Figure 4---figure supplement 6](#fig4s6){ref-type="fig"}.

B\) In [Figure 3---source data 1](#SD1-data){ref-type="supplementary-material"}, we have added the following information: ([@bib1]) the ten proteins were mixed at equal amounts by mass; ([@bib2]) the pdb codes. Taking the undiluted ten-protein mix as an example, of the 61 identified Leiker cross-links that can be mapped to the pdb structures, 82% have Cα -- Cα distance ≤22 Å and 93% have Cα -- Cα distance ≤30 Å (FDR \< 5%, E-value \< 0.01). Of the 48 BS~3~ cross-links that can be mapped to the pdb structures, 94% have Cα -- Cα distance ≤24 Å and 96% have Cα -- Cα distance ≤ 30 Å (FDR \< 5%, E-value \< 0.01). This information has been added to [Figure 3---source data 2](#SD2-data){ref-type="supplementary-material"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.

6\) The authors utilize identification of artefactual inter-protein crosslinks to assess the specificity of the trifunctional reagents versus BS~3~. It is also of interest to ascertain whether these larger reagents are more sterically hindered in accessing reactive amines. This requires comparing data obtained on standards such as the 10 proteins using e.g. BS~3~

*versus the tri-functional reagents. Since this data already exists, it appears straightforward to make this comparison. Indeed from [Figure 3A](#fig3){ref-type="fig"} it appears that their technique yields approximately 50% less of crosslinks comparing to DSS. This point needs to be properly addressed.*

It is a theoretical concern that Leiker may be more sterically hindered in accessing reactive amines because it is larger than BS~3~. However, we did not find clear evidence for it. Using the cross-links from the ten-protein mix (FDR \< 0.05, E-value \< 0.01), we find that the overlap between two BS~3~ experiments is similar to the overlap between a BS~3~ experiment and a Leiker experiment ([Author response image 4](#fig65){ref-type="fig"}). The decrease in Leiker cross-links without enrichment might have to do with the negative effect of the biotin group, which is removed after enrichment. We are of the opinion that most of the differences are due to variations unrelated to cross-linking chemistry.10.7554/eLife.12509.097Author response image 4.Overlap between two CXMS experiments using BS~3~ or Leiker on the same 10-protein mix.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.097](10.7554/eLife.12509.097)

*7) In the experimental data shown in [Figure 3](#fig3){ref-type="fig"}, the authors found that even in a 100-fold excess of E. coli lysate over the protein standards approx. 97% of the identified peptides were crosslinked peptides -- i.e., they observed something like a 100-fold enhancement of crosslinked peptides under these conditions. However in the E. coli lysate, the authors only observed a 4-fold increase in the crosslinks treated with tri-functional reagents compared to that treated with BS~3~*

*([Figure 3B](#fig3){ref-type="fig"}). The authors need to explain this observation? (This question is related to 16 below).*

The difference is due to the experimental design. In the experiment of [Figure 3A](#fig3){ref-type="fig"}, the tryptic digest of a cross-linked ten-protein mixture was diluted with the tryptic digest of a non-cross-linked *E. coli* lysate. In the experiment of [Figure 3B](#fig3){ref-type="fig"}, it's the *E. coli* lysate that was cross-linked. The amount of non-cross-linked peptides in the first experiment greatly exceeded that in the second one. Because these non-cross-linked peptides were depleted after enrichment, the first experiment saw a greater enhancement in cross-link identification.

*8) Crosslinks do not necessarily define direct protein-protein interactions due to their relatively long distance thresholds (here \>25 angstroms), although in many cases they do. Thus, it is more accurate to interpret the data as defining \"protein spatial connectivity\" or \"spatial restraints\" instead.*

We have replaced "direct protein-protein interactions" with "putative direct protein-protein interactions". The term of protein spatial connectivity is very accurate but too technical for a general readership.

*9) The crosslink data appears sparse by current day standards. Discuss why you think this is the case. How much material was used in the ribosome crosslinking study?*

A\) We are not sure what standards the reviewers are referring to. The number of *E. coli* cross-links identified in this study is four times greater than the number of PIR-identified inter-links (Chavez, et al., 2013) and eight times greater than the number of BS~3~-identified inter-links (Yang, et al., 2012). The number of cross-links identified from *C. elegans* is fewer that from *E. coli*. Among the possible reasons are greater sample complexity, the dominance of vitellogenin and cytoskeletal proteins in *C. elegans* lysates, fewer replicate experiments, less extensive peptide fractionation, and a search space several orders of magnitude larger.

B\) 30 μg of ribosomes were used in each replicate experiment.

10\) Concerning the application of the described method to an analysis of crosslinking of proteins within lysates, it is of interest to provide data on the relative information provided in the three independent experiments to give the reader a feel for the amount of data that can be expected from a single experiment as well as their reproducibility. The authors should further discuss \'half of the BS~3~

*identified cross-links from E. coli were recapitulated in this study\' (subsection "Application of Leiker to lysates", second paragraph)? If after enrichment 50% of previously identified crosslinkers are not identified, does it mean that the generated crosslinks themselves vary dramatically or the enrichment is simply not exhaustive enough? For that reason the authors should state how much overlap there is between the crosslinks of the biological replicates.*

A\) The biological replicates of the *E. coli* whole-cell lysate yielded 1407, 1230, and 1474 cross-linked lysine pairs (FDR \< 0.05, E-value \< 0.01, and spectral count ≥ 3, same below), respectively, with 737 detected in all three replicates. The biological replicates of the *E. coli* ribo-free lysate resulted in 1512, and 1745 cross-linked lysine pairs, respectively, with an overlap of 1286 cross-links. This information is added to the revised manuscript as [Figure 5---figure supplement 2D](#fig5s2){ref-type="fig"}.

B\) We think that inadequate sampling of LC-MS/MS experiments is the major reason why half of BS~3~ cross-links of *E. coli* proteins were not identified using Leiker. In any sample there is always a population of cross-linked peptides that are barely detectable, and they may or may not be identified in an LC-MS/MS analysis. When identified, they typically have only one or a few spectral counts. As shown in [Author response image 4](#fig65){ref-type="fig"} (left panel), even for a sample containing only ten standard proteins, the overlap between two BS~3~ cross-linking experiments is around 50%. The overlap improves if a sample is analyzed repeatedly (technical repeats). For example, on *E. coli* lysates, the overlap between two ribo-free data sets, each with three technical repeats, is much better than the overlap between two whole-cell data sets, each with two technical repeats.

11\) Crosslink data analysis. For their large database searches, did the authors try to filter and estimate the FDRs separately for intersubunit and intersubunit crosslinks? (Trnka et al.

*MCP, 2014). If not, the authors could, for example, search their 70S dataset using two different databases: either a small database (containing only the ribosome proteins) or a large database (with hundreds of proteins) and compare the differences (mapped to the available atomic structure). In any event, the authors should to upload their inter-peptide spectra to allow the interested reader to assess the crosslinked peptides data quality (scores do not always allow this because the good score may be dominated by one of the two peptides within the pair).*

A\) The inter-subunit and intra-subunit cross-links were filtered together.

B\) In the manuscript, MS2 spectra were searched against a small database consisting of 54 ribosomal proteins and 8 ribosome-associated proteins that were identified in the sample (54 + 8 = 62 proteins). As suggested, we added 500 other *E. coli* proteins to the database, repeated the search, and identified 192 cross-linked lysine pairs, 190 of which have been identified in the small database search ([Author response image 5](#fig66){ref-type="fig"}). The two unique cross-links identified in the large database search are between a ribosomal protein and a non-ribosomal protein, and cannot be mapped to the crystal structures of ribosomes.10.7554/eLife.12509.098Author response image 5.Comparison of identified cross-links using a small database (62 proteins) and a large database (562 proteins).Filtering criteria: FDR \< 5%, E-value \< 0.00001, and spectral count ≥ 5.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.098](10.7554/eLife.12509.098)

C\) We've deposited the raw data of the 70S ribosomes to <http://www.huanglab.org.cn/donglab/RAW_6bio/>.

*12) It is in the first paragraph of the subsection "Application of Leiker to lysates" that most of the inter-molecule cross-links suggest novel protein-protein interactions. Exactly how was this assessed?* We and others have demonstrated that inter-protein cross-links identified with high confidence generally indicate protein-protein interactions (Yang, et al., 2012; Herzog, et al., 2012; Liu, et al., 2015). This is well accepted in the field.

*13) I find [Figure 5](#fig5){ref-type="fig"} to be largely uninformative. The authors must find a more informative way of presenting this or part of this data. It seems likely that the observed inter-molecule interactions are strongly skewed by the relative abundance of the proteins in the lysates. An assessment of this data in terms of the abundance of the proteins could provide valuable information on the rules underlying the observation of interaction in such complex mixtures. Depending on the results, it might also be valuable to discuss other possible reasons for why these particular interactions are observed.*

A\) We have moved [Figure 5](#fig5){ref-type="fig"} to [Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}.

B\) Yes, inter-molecular cross-links between high-abundance proteins are more readily observable than those of low-abundance proteins. In the *E. coli* whole-cell lysates, inter-protein cross-links are dominated by those of ribosomal proteins; when ribosome are removed (the ribo-free sample), cross-links of other proteins emerged ([Figure 5B](#fig5){ref-type="fig"}). The 617 inter-molecular cross-links identified in the *E. coli* whole-cell lysate involve 341 proteins, 256 of which have their abundances determined in a recent study (Schmidt, et al., 2016). The number of inter-molecular cross-links observed is positively correlated with protein abundance ([Author response image 6](#fig67){ref-type="fig"}).10.7554/eLife.12509.099Author response image 6.The number of inter-molecular cross-links observed for a protein in *E. coli* whole-cell lysates is positively correlated with the abundance of this protein.R, Pearson correlation coefficients; N, number of values.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.099](10.7554/eLife.12509.099)

*14) I could not make sense of the sentence "Applying the same procedure to the previously identified BS^3^ cross-links (Yang, et al., 2012), we obtained only three ribosomal proteins in the most highly connected modules ([Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"})", nor could I find [Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}. Indeed I was unable to make proper sense of the second half of the subsection "Application of Leiker to lysates". I also did not find the recitation of numbers in this section particularly useful or meaningful. The points that I think are ostensibly being made in this section need to be made much more clearly.*

We have replaced [Figure 5](#fig5){ref-type="fig"} with [Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}. The content of the subsection "Application of Leiker to lysates" has been revised to focus on the main point that Leiker is a good reagent for mapping protein-protein interaction networks.

*15) The data from the whole-proteome CX-MS analysis of C. elegans appears sparse (with just a few hundred crosslinks identified). What is the reason for this? (See also Q 16). Is this because of limitations of the software? If this is the case, perhaps it would help to use a smaller database containing only the top 1,000 most abundant proteins (since identifying crosslinks from the less abundant proteins would appear unlikely anyway)?*

A\) To find out if this has to do with the database size, we repeated the search using two smaller databases, one containing only the top 1,000 most abundant proteins as the reviewers suggested, and the other containing 363 proteins for which intra-molecular cross-links had been identified in the initial pLink search. This resulted in a 10-20% increase in the number of cross-links identified ([Author response image 7](#fig68){ref-type="fig"}), so the database size is a factor but not a critical one.

B\) For the *C. elegans* samples, fewer replicate experiments were performed and the peptides were separated into fewer fractionations (Author response [table 2](#tbl2){ref-type="table"}), accounting at least in part for the decrease of cross-link identifications.

C\) Other possible explanations include the greater complexity of the *C. elegans* lysate and the dominance of vitellogenins and cytoskeletal proteins in the lysates.10.7554/eLife.12509.100Author response image 7.Comparison of identified cross-links using databases of different size.db9346, containing all the proteins identified in the sample; db1000, containing the top 1000 abundant proteins; db363, containing all the proteins for which intra-molecular cross-links had been identified. Filtering criteria: FDR \< 5%, E-value \< 0.01, and spectral count ≥ 3.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.100](10.7554/eLife.12509.100)10.7554/eLife.12509.101Author response table 2.Replicates of the *E. coli* and *C. elegans* lysates.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.101](10.7554/eLife.12509.101)SampleBiologicalReplicateTechnicalReplicateFractionation*E. coli* whole-cell lysates3210-11 fractions*E. coli* ribo-free lysates2310-12 fractions*C. elegans* whole-cell lysates128 fractions*C. elegans* mitochondrial proteins129 fractions

*16) While I agree with the authors that better sample preparation and more sensitive instrumentation could help to reduce the crosslinking problem caused by the huge dynamic range of proteins within proteomes, I am not convinced that these are actually the most important barriers to overcome for proteome-wide crosslinking profiling for at least two reasons:*

*A) Within cells, the majority of protein complexes are not abundant. Thus, using the current crosslinking protocol without prior affinity enrichment of the complexes of interest, the majority of such complexes will not be efficiently crosslinked because of the low efficiency for crosslinking low abundance complexes.*

We think that proteome-wide cross-linking are effective for high- and medium-abundance protein complexes if combined with extensive protein-level fractionation. Low-abundance protein complexes are always a challenge; even affinity purification may not succeed in every case.

Although many signaling protein complexes are of low abundance, many structural protein complexes (e.g. nuclear pore complex) and those that function in fundamental biological processes (e.g. RNA polymerase II complex, spliceosome, proteasome, exosome) are quite abundant.

*B) And even if one could crosslink the proteome efficiently using more efficient reagents, glueing the cellular components together would likely lead to daunting challenges in inducing the needed proteolysis.*

As demonstrated using ten standard proteins ([Figure 3---source data 2](#SD2-data){ref-type="supplementary-material"}), the cross-linking reaction of Leiker is as specific as that of BS~3~. We are not willing to increase reaction efficiency at the risk of reducing specificity. The proteolysis challenge may be solved by using multiple proteases as suggested by Leitner A et al. (Leitner, et al., 2012). Lys-C is a good choice as it allows digestion to be carried out in 8 M urea, which unfolds proteins and exposes more polypeptides to digestion.

*17) [Figure 8](#fig8){ref-type="fig"}. Reliable quantitative CX-MS analysis can be very challenging due to the low abundance of crosslink ions. What is the reproducibility of the quantitative data? Error bars from the repeat experiments would help here. Indeed without stronger quantitative data, it is not justified to entitle the paper: \"Leiker, A Cross-Linker for Mapping Protein-Protein Interaction Networks and comparative cross-link analysis\" at least with respect to the \"aspect of comparative cross-link analysis\".*

A\) The experiment for [Figure 8](#fig8){ref-type="fig"} (log phase vs. stationary phase *E. coli* lysates) was performed only once, but the forward and the reverse labeling experiments serve the purpose of biological replicates. Between the forward and reverse experiments, the Pearson correlation coefficients on inter- and mono-links are 0.55 and 0.60, respectively, suggesting that the two experiments are generally consistent with each other.

B\) For L7Ae, three biological replicates were performed for both forward and reverse labeling experiments. The quantification results of each replicate are shown in [Figure 7---source data 1](#SD11-data){ref-type="supplementary-material"}. Shown below is a scatter plot with error bars for this data set ([Author response image 8](#fig69){ref-type="fig"}).10.7554/eLife.12509.102Author response image 8.Abundance ratios of mono-links (F/B) in the forward (F~\[d0\]~/B~\[d6\]~) and the reverse labeling experiment (F~\[d6\]~/B~\[d0\]~).Mean ± SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.12509.102](10.7554/eLife.12509.102)

[Author response image 8](#fig69){ref-type="fig"}

\[Editors\' note: further revisions were requested prior to acceptance, as described below.\]

The manuscript has been improved but there are some remaining issues that need to be addressed before acceptance, as outlined below: Concerning the title, it is not acceptable to us that you use the acronym LEIKER (Lysine-targeted enrichable cross-linker) in the title or Abstract of the paper. We note that you have now acceded to the request to properly attribute the 2003 JACS article, which previously described trifunctional reagents with the same basic properties as the present trifunctional reagent. We note that you still wish to name your process by an acronym (Lysine-targeted enrichable cross-linker (Leiker) even though this was thought to be inappropriate by the reviewers. The reviewers\' objection to the acronym was that in giving a new name to a previously published strategy, you might effectively take possession of an idea that did not originate with the present work. Therefore, in order for this work to be published in eLife, you may use the acronym LEIKER in the main body of the paper, but not in the title or the Abstract.

We have revised the title to "Trifunctional Cross-Linker for Mapping Protein-Protein Interaction Networks and Comparing Protein Conformational States", and removed the acronym "Leiker" from the Abstract.

[^1]: These authors contributed equally to this work.
